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General. Unless stated otherwise, all reactions were carried out in flame-dried glassware 
using anhydrous solvents under Argon. The solvents were purified by distillation over the 
following drying agents and were transferred under Ar: THF, Et2O (Mg/anthracene), CH2Cl2, 
hexane, pentane, toluene (Na/K), MeOH (Mg, stored over MS 3 Å), EtOH (MS 3 Å), ethyl 
acetate (P2O5, filtered through dry Al2O3, stored over 4 Å MS); 1,4-dioxane, DMF, MeCN, 
NEt3 and pyridine were dried by an adsorbtion solvent purification system based on molecular 
sieves. Thin layer chromatography (TLC): Macherey-Nagel precoated plates (POLYGRAM
®
 
SIL/UV254); Flash chromatography: Merck silica gel 60 (40–63 µm) with predistilled or 
HPLC grade solvents. NMR: Spectra were recorded on Bruker DPX 300, AV 400, AV 500 or 
AVIII 600 spectrometer in the solvents indicated; chemical shifts (δ) are given in ppm relative 
to TMS, coupling constants (J) in Hz. The solvent signals were used as references and the 
chemical shifts converted to the TMS scale (CDCl3: δC 77.2 ppm; residual CHCl3 in CDCl3: 
δH 7.26 ppm; CD3OD: δC49.0 ppm; residual CHD2OD: δH3.31 ppm). IR: Spectrum 
One (Perkin-Elmer) spectrometer, wavenumbers (~ ) in cm1. MS (EI): Finnigan MAT 8200 
(70 eV), ESI-MS: ESQ3000 (Bruker), accurate mass determinations: Bruker APEX III FT-
MS (7 T magnet) or Mat 95 (Finnigan). Optical rotations (  20D ) were measured with a 
Perkin-Elmer Model 343 polarimeter. LC-MS analyses were conducted on a Shimadzu LC-
MS2020 instrument (pumps LC-20AD, autosampler SIL-20AC, column oven CTO-20AC, 
diode array detector SPD-M20A, controller CBM-20A, ESI detector and software Lab-
solutions) with an ZORBAX Eclipse Plus C18 1.8 µm, 3.0 or 4.6 mm ID × 50 mm (Agilent). 
A binary gradient of MeCN or MeOH in water or aq. triethylammonium acetate buffer (10 
mmol. pH 8) was used at a flow rate of 0.5 (3.0 mm ID) or 0.8 (4.6 mm ID) mL/min. The 
oven temperature was kept at 35 °C and the detection wave length at 254 nm. Preparative LC 
was performed with a Shimadzu LC-20A prominence system (pumps LC-20AP, column oven 
CTO-20AC, diode array detector SPD-M20A, fraction collector FRC-10A, controller CBM-
20A and software LC-solution); conditions for each compound are specified below. Unless 
stated otherwise, all commercially available compounds (Alfa Aesar, Aldrich, Fluka, TCI) 








 A suspension of (R)-(+)-3-butyn-2-ol (5.96 mL, 
75.6 mmol) and copper(I) iodide (14.4 g, 75.6 mmol) in toluene (100 mL) was 
cooled to −78 °C. A solution of methylmagnesium bromide (1.4 M in THF/toluene 
1:3, 378 mL, 529 mmol) was added over the course of 75 min. Once the addition 
was complete, the mixture was allowed to warm to ambient temperature and stirring was 
continued for 3.5 h. The mixture was then cooled to −40 °C before a solution of iodine (134 g, 
529 mmol) in THF (140 mL) was slowly added via cannula. After stirring 1.5 h at room 
temperature, the reaction was carefully quenched by the addition of sat. aq. sodium thiosulfate 
(400 mL). The aqueous phase was extracted with Et2O (3 × 200 mL) and the combined 
extracts were dried over MgSO4, filtered and concentrated by distillation (in portions, 40 °C, 
≥90 mbar, Vigreux column, collection flask cooled to −78 °C). The residue (200 mL) was 
purified by flash chromatography (pentane/Et2O, 7:1 to 6:1) and the product containing 
fractions were concentrated by careful distillation (40 °C, ≥200 mbar) to yield the title 
compound (93% in Et2O, 12.7 g, 74%) as a pale orange liquid.  20D  = +12.3 (c = 2.65, 
CHCl3); 
1
H NMR (400 MHz, CDCl3): δ = 5.89-5.88 (m, 1H), 4.77 (qd, J = 6.5, 2.8 Hz, 1H), 
1.87 (d, J = 1.5 Hz, 3H), 1.79-1.78 (m, 1H) 1.25 (d, J = 6.5 Hz, 3H); 
13
C NMR (100 MHz, 
CDCl3): δ = 149.4, 73.7, 72.6, 20.4, 18.4; IR (film): 
~  = 3331, 2973, 2916, 16134, 1441, 
1369, 1278, 1134, 1102, 1073, 1037, 1021, 975, 902, 770 cm
−1
; MS (EI) m/z (%): 127 (3), 85 




 A solution of the alcohol S1 (93% in Et2O, 
12.7 g, 55.7 mmol) in THF (80 mL) was added over 10 min to a suspension of 
sodium hydride (2.67 g, 111 mmol) and imidazole (379 mg, 5.57 mmol, 0.10 
equiv) in THF (150 mL) at 0 °C. The mixture was allowed to reach ambient 
temperature and stirring was continued for 2 h before methyl iodide (31.6 g, 223 mmol) was 
added slowly. After an additional 2 h, the excess reagent was quenched with water (250 mL) 
and the aqueous layer was extracted with pentane (2 × 250 mL). The combined extracts were 
washed with brine (200 mL), dried over MgSO4, filtered and concentrated by careful 
distillation (25 °C, ≥350 mbar, Vigreux column, collection flask cooled to −78 °C). The 
residue (ca. 100 mL) was purified by flash chromatography (pentane/Et2O, 20:1) and product-
containing fractions were concentrated by distillation (30 °C, ≥300 mbar) to yield compound 
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5 as an yellowish liquid (95% in pentane, 8.44 g, 64%).  20D  = +5.3 (c = 2.55, CHCl3); 
1
H 
NMR (400 MHz, CDCl3): δ = 6.03-6.02 (m, 1H), 4.26 (q, J = 6.5 Hz, 1H), 3.22 (s, 3H), 1.79 
(d, J = 1.5 Hz, 3H), 1.19 (d, J = 6.5 Hz, 3H); 
13
C NMR (100 MHz, CDCl3): δ = 147.5, 80.9, 
75.8, 56.4, 18.6, 18.1; IR (film): ~  = 2978, 2928, 2820, 1613, 1441, 1369, 1339, 1279, 1205, 
1144, 1114, 1094, 1064, 1030, 968, 865, 773. cm
−1
; MS (EI) m/z (%): 195 (3), 127 (2), 99 




 In a pressure 
tube, palladium(II) acetate (265 mg, 1.18 mmol, 5 mol%) was added to a 
suspension of caesium carbonate (15.4 g, 47.3 mmol), ethyl-4-
oxazolcarboxylate 6 (3.3 g, 23.6 mmol), alkenyl iodide 5 (95% in 
pentane, 8.44 g, 35.5 mmol) and 2-(dicyclohexylphosphino)biphenyl 
(829 mg, 2.36 mmol, 10 mol%) in 1,4-dioxane (65 mL). The mixture 
was stirred at 110 °C for 23 h. After cooling to ambient temperature, the suspension was 
filtered through Celite which was carefully rinsed with CH2Cl2 (50 mL). The filtrate was 
concentrated under reduced pressure (40 °C, ≥50 mbar) and the residue was purified by flash 
chromatography (hexanes/ethyl acetate, 20:1 to 4:1) to yield compound 7 (4.16 g, 74%) as a 
colorless oil.  20D  = +41.7 (c = 1.76, CHCl3); 
1
H NMR (400 MHz, CDCl3): δ = 8.13 (s, 1H), 
6.25 (s, 1H), 5.13 (q, J = 6.4 Hz, 1H), 4.38 (q, J = 7.0 Hz, 2H), 3.22 (s, 3H), 1.92 (d, J = 1.5 
Hz, 3H), 1.37 (d, J = 7.0 Hz, 3H), 1.32 (d, J = 6.5 Hz, 3H); 
13
C NMR (100 MHz, CDCl3): δ = 
161.6, 161.2, 153.4, 142.9, 134.4, 112.9, 75.0, 61.4, 56.7, 19.6, 18.1, 14.5; IR (film): ~  = 
3154, 2981, 2932, 2821, 1743, 1720, 1654, 1575, 1562, 1447, 1370, 1332, 1316, 1279, 1217, 
1178, 1109, 1025, 971, 947, 839, 771 cm
−1
; MS (EI) m/z (%): 224 (100), 194 (7), 180 (3), 59 
(9); HRMS (ESI): m/z: calcd. for C12H17NO4Na [M+Na
+




 A solution of 
oxazole 7 (4.20 g, 17.6 mmol) in CH2Cl2 (150 mL) was cooled to −90 
°C and treated dropwise over 15 min with Dibal-H (1 M in toluene, 35.1 
mL, 35.1 mmol). The mixture was stirred at −90 °C until TLC showed 
complete consumption of the starting material (ca. 20 min). The excess 
reagent was carefully quenched by the addition of methanol (15 mL) and sat. aq. potassium 
sodium tartrate (200 mL). The mixture was stirred for 18 h at 23 °C before the layers were 
separated and the aqueous phase was extracted with CH2Cl2 (3 × 150 mL). The combined 
extracts were washed with brine (200 mL), dried over MgSO4, filtered and concentrated. The 
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residue was purified by flash chromatography (hexanes/ethyl acetate, 15:1 to 10:1) to give 
product 8 (2.74 g, 80%) as a yellowish oil.  20D  = +46.8 (c = 2.18, CHCl3); 
1
H NMR (400 
MHz, CDCl3): δ = 9.93 (s, 1H), 8.16 (s, 1H), 6.23-6.22 (m, 1H), 5.24 (q, J = 6.5 Hz, 1H), 3.23 
(s, 3H), 1.94 (d, J = 1.5 Hz, 3H), 1.32 (d, J = 6.6 Hz, 3H); 
13
C NMR (100 MHz, CDCl3): δ = 
184.7, 161.4, 154.7, 142.9, 141.7, 112.1, 74.9, 56.7, 19.3, 18.0; IR (film): ~  = 3144, 3085, 
2979, 2932, 2822, 1698, 1652, 1563, 1447, 1393, 1381, 1326, 1290, 1206, 1149, 1113, 1096, 
1069, 833, 759 cm
−1
; MS (EI) m/z (%): 195 (15), 180 (100), 59 (6); HRMS (ESI): m/z: calcd. 
for C10H13NO3Na [M+Na
+
]: 218.0787 found: 218.0789. 
 
(S)-1-(2-((R,Z)-3-Methoxy-2-methylbut-1-en-1-yl)oxazol-4-yl)but-3-en-1-ol (9). Powdered 
molecular sieves 4 Å (5 g, activated for 5 days at 120 °C) and 
titanium(IV) isopropoxide (411 µL, 1.39 mmol, 10 mol%) were added 
to a solution of (S)-(−)-1,1′-bi(2-naphthol) (398 mg, 1.39 mmol, 10 
mol%) in CH2Cl2 (25 mL). The orange suspension was stirred at reflux 
temperature for 1 h before it was allowed to cool to ambient 
temperature. A solution of aldehyde 8 (2.71 g, 13.9 mmol) in CH2Cl2 (15 mL) was added. The 
mixture was cooled to −78 °C before allyltributylstannane (5.25 mL, 16.9 mmol) was added 
dropwise. After 3 days at −30 °C, TLC showed complete consumption of the starting 
material. The reaction was quenched with sat. aq. NaHCO3 (25 mL) and the mixture allowed 
to reach ambient temperature. The suspension was filtered through a plug of Celite which was 
carefully rinsed with tert-butyl methyl ether (25 mL). The filtrate was concentrated until good 
separation of the layers was reached. The aq. phase was extracted with tert-butyl methyl ether 
(2 × 25 mL) and the combined extracts were dried over MgSO4, filtered and concentrated. 
The residue was purified by flash chromatography (hexanes/ethyl acetate, 15:1 to 4:1) to give 
the title compound (3.21g, 98%) as a pale yellow oil. The de > 95% was determined by 
analysis of the derived Mosher esters).  20D  = +22.3 (c = 0.50, CHCl3); 
1
H NMR (400 MHz, 
CDCl3): δ = 7.46 (s, 1H), 6.19 (s, 1H), 5.84 (ddt, J = 17.2, 10.3, 7.1 Hz, 1H), 5.20-5.14 (m, 
3H), 4.73 (dd, J = 7.3, 5.6 Hz, 1H), 3.22 (s, 3H), 2.69-2.62 (m, 1H), 2.59-2.52 (m, 1H), 2.39 
(br s, 1H), 1.89 (d, J = 1.4 Hz, 3H), 1.30 (d, J = 6.4 Hz, 3H); 
13
C NMR (100 MHz, CDCl3): δ 
= 160.7, 151.1, 144.0, 134.0, 133.2, 118.8, 113.5, 75.0, 66.7, 56.7, 41.1, 19.4, 17.8; IR (film): 
~  = 3417, 2980, 2933, 1655, 1642, 1542, 1539, 1381, 1371, 1206, 1154, 1113, 1095, 1068, 
915, 862. cm
−1
; MS (EI) m/z (%): 237 (38), 222 (56), 204 (100); HRMS (ESI): m/z: calcd. for 
C13H19NO3Na [M+Na
+





carbonate (10). Di-tert-butyl dicarbonate (7.30 g, 33.5 mmol) and 4-
(dimethylamino)pyridine (1.02 g, 8.37 mmol) were added to a 
solution of the alcohol 9 (3.79 g, 17.7 mmol) in MeCN (150 mL). 
After stirring for 20 h, the mixture was concentrated and the residue 
was dissolved in tert-butyl methyl ether (100 mL) and water (100 
mL). The layers were separated and the aqueous phase was extracted with tert-butyl methyl 
ether (2 × 100 mL). The combined extracts were dried over Na2SO4, filtered and concentrated. 
The crude product was purified by flash chromatography (hexanes/ethyl acetate, 15:1 to 10:1) 
to yield the title compound (5.18 g, 92%) as a pale yellow oil.  20D  = 8.8 (c = 0.60, CHCl3); 
1
H NMR (400 MHz, CDCl3): δ = 7.51 (d, J = 0.4 Hz, 1H), 6.19-6.18 (m, 1H), 5.76 (ddt, J = 
17.2, 10.1, 7.1 Hz, 1H), 5.62 (t, J = 6.5 Hz, 1H), 5.21 (q, J = 6.5 Hz, 1H), 5.13 (dq, J = 17.2, 
1.6 Hz, 1H), 5.08-5.05 (m, 1H), 3.22 (s, 3H), 2.78 (ddt, J = 14.3, 6.6, 1.5 Hz, 1H), 2.71 (ddt, J 
= 14.2, 7.1, 1.2 Hz, 1H), 1.88 (d, J = 1.4 Hz, 3H), 1.47 (s, 9H), 1.31 (d, J = 6.5 Hz, 3H); 
13
C 
NMR (100 MHz, CDCl3): δ = 160.6, 153.1, 151.2, 140.1, 134.9, 133.0, 118.5, 113.4, 82.6, 
74.9, 71.2, 56.9, 37.8, 28.0 (3C), 19.3, 17.8; IR (film): ~  = 2980, 2933, 2820, 1740, 1644, 
1544, 1449, 1369, 1342, 1280, 1254, 1163, 1095, 1036, 973, 919, 845, 793, 762 cm
−1
; MS 
(EI) m/z (%): 337 (15.86), 281 (18.30), 220 (57.00), 204 (100), 117 (2); HRMS (ESI): m/z: 
calcd. for C18H27NO5Na [M+Na
+
]: 360.1781 found: 360.1783. 
 
(4R,6S)-4-(Iodomethyl)-6-(2-((R,Z)-3-methoxy-2-methylbut-1-en-1-yl)oxazol-4-yl)-1,3-
dioxan-2-one (11). A solution of olefin 10 (3.97 g, 11.8 mmol) in 
toluene (140 mL) was cooled to −90 °C and treated dropwise with 
a solution of IBr (1 M in CH2Cl2, 35.3 mL, 35.3 mmol) over 40 min 
(it was essential to store the IBr solution at 23 °C). After complete 
addition, stirring was continued until TLC showed complete 
consumption of the starting material (ca. 10 min). The excess 
reagent was quenched with sat. aq. NaHCO3 (100 mL) and sat. aq. sodium thiosulfate 
(100 mL). After reaching ambient temperature, the layers were separated and the aq. phase 
was extracted with tert-butyl methyl ether (2 × 150 mL). The combined extracts were dried 
over Na2SO4, filtered and concentrated. The crude material was purified by flash 
chromatography (hexanes/ethyl acetate, 2:1) to yield the title compound (2.58 g, 54%) as a 
pale yellow oil. When the reaction was performed with only 200 mg of 10, a yield of 73% 
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was obtained.  20D  = +21.7 (c = 0.79, CHCl3). 
1
H NMR (400 MHz, CDCl3): δ = 7.56 (d, J = 
0.7 Hz, 1H), 6.19 (s, 1H), 5.50 (ddd, J = 11.7, 3.1, 0.7 Hz, 1H), 5.15 (q, J = 6.3 Hz, 1H), 4.64-
4.58 (m, 1H), 3.46 (dd, J = 10.5, 4.4 Hz, 1H), 3.46 (dd, J = 10.5, 7.6 Hz, 1H), 3.23 (s, 3H), 
2.78 (dt, J = 14.1, 3.19 Hz, 1H), 2.15 (dt, J = 14.3, 11.1 Hz, 1H), 1.92 (d, J = 1.7 Hz, 3H), 
1.30 (d, J = 6.6 Hz, 3H); 
13
C NMR (100 MHz, CDCl3): δ = 161.3, 152.7, 147.9, 138.5, 134.9, 
112.9, 74.9, 73.5, 69.5, 56.7, 33.0, 19.4, 17.9, 4.9; IR (film): ~  = 3482, 3135, 2978, 2931, 
2820, 1745, 1656, 1602, 1543, 1519, 1446, 1382, 1239, 1184, 1109, 1092, 1038, 971, 854, 
760 cm
−1
; MS (ESI) m/z (%): 430 (M+Na
+
, 100); HRMS (ESI): m/z: calcd. for C14H18NO5INa 
[M+Na
+
]: 430.0121 found: 430.0120. 
 
(S)-1-(2-((R,Z)-3-Methoxy-2-methylbut-1-en-1-yl)oxazol-4-yl)-2-((R)-oxiran-2-yl)ethan-1-
ol (S2). A solution of iodide 11 (2.11 g, 5.18 mmol) in MeOH (25 
mL) was treated at 0 °C with potassium carbonate (2.15 g, 15.5 
mmol). After stirring for 40 min, the mixture was diluted with tert-
butyl methyl ether (25 mL) and excess reagent was quenched with 
sat. aq. ammonium chloride (50 mL). The aq. phase was extracted 
with tert-butyl methyl ether (2 × 25 mL) and the combined extracts were dried over MgSO4, 
filtered and concentrated. The residue was purified by flash chromatography (hexanes/ethyl 
acetate, 1:1) to yield the title compound (1.03 g, 79%) as a colorless oil.  20D  = +28.0 (c = 
0.30, CHCl3); 
1
H NMR (400 MHz, CDCl3): δ = 7.51 (s, 1H), 6.19 (s, 1H), 5.18 (q, J = 6.6 Hz, 
1H), 4.94 (t, J = 5.7 Hz, 1H), 3.22 (s, 3H), 3.17-3.09 (m, 1H) 2.80 (dd, J = 4.8, 4.1 Hz, 1H), 
2.72 (d, J = 4.3 Hz, 1H), 2.57 (dd, J = 5.9, 2.6 Hz, 1H), 2.27 (dt, J = 14.4, 4.5 Hz, 1H), 1.90 
(d, J = 1.5 Hz, 3H), 1.92-1.81 (m, 1H), 1.30 (d, J = 6.6 Hz, 3H); 
13
C NMR (100 MHz, 
CDCl3): δ = 160.9, 151.3, 143.9, 133.4, 113.5, 75.0, 66.3, 65.8, 50.3, 47.0, 39.4, 19.4, 18.9; 
IR (film): ~  = 3417, 2980, 2824, 2821, 1655, 1542, 1518, 1447, 1370, 1258, 1206, 1152, 
1206, 1152, 1109, 1094, 1068, 1036, 971, 856, 753 cm
−1
; MS (EI) m/z (%): 253 (13), 238 
(53), 178 (100); HRMS (ESI): m/z: calcd. for C13H19NO4Na [M+Na
+




2-((R,Z)-3-methoxy-2-methylbut-1-en-1-yl)oxazole (12). TBSCl 
(1.25 g, 8.29 mmol) was added to a solution of alcohol S2 (1.40 g, 
5.53 mmol), imidazole (564 mg, 8.29 mmol) and 4-
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(dimethylamino)-pyridine (67.5 mg, 0.553 mmol, 10 mol%) in CH2Cl2 (5.5 mL) at 0 
o
C. The 
mixture was stirred at ambient temperature until TLC showed complete consumption of the 
starting material (ca. 75 min). The mixture was diluted with tert-butyl methyl ether (20 mL) 
and excess reagent was quenched with sat. aq. ammonium chloride (30 mL). The aqueous 
phase was extracted with tert-butyl methyl ether (2 × 30 mL). The combined extracts were 
dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
chromatography (hexane to hexanes/ethyl acetate, 30:1) to give the title compound (1.99 g, 
98%) as a yellow oil.  20D  = +13.2 (c = 0.44, CHCl3); 
1
H NMR (400 MHz, CDCl3): δ = 7.45 
(d, J = 0.7 Hz, 1H), 6.18 (dd, J = 1.2, 0.7 Hz, 1H), 5.21 (q, J = 6.2 Hz, 1H), 4.92 (td, J = 5.8, 
1.1 Hz, 1H), 3.23 (s, 3H), 3.04 (m, 1H), 2.74 (t, J = 4.8 Hz, 1H), 2.50 (dd, J = 5.0, 2.7 Hz, 
1H), 2.11 (dt, J = 13.9, 5.8 Hz, 1H), 1.93 (dt, J = 13.9, 5.8 Hz, 1H), 1.89 (d, J = 1.4 Hz, 3H), 
1.29 (d, J = 6.4 Hz, 3H), 0.9 (s, 9H), 0.1 (s, 3H), 0.04 (s, 3H); 
13
C NMR (100 MHz, CDCl3): 
δ = 160.3, 150.7, 145.1, 133.7, 113.5, 74.9, 67.0, 56.6, 49.4, 47.0, 40.7, 25.8 (3C), 19.2, 18.2, 
17.7, −4.6, −4.8; IR (film): ~  = 2954, 2929, 2887, 2857, 2820, 1654, 1542, 1472, 1463, 1447, 
1408, 1387, 1362, 1253, 1206, 1153, 1093, 1034, 1006, 968, 938, 913, 871, 833, 811, 775, 
811, 775 cm
−1
; MS (EI) m/z (%): 367 (5), 336 (2), 310 (100); HRMS (ESI): m/z: calcd. for 
C19H33NO4SiNa [M+Na
+




Preparation of the Grignard reagent 13:
3
 A solution of 2-(2-
bromoethyl)-1,3-dioxolane (2.00 mL, 17.0 mmol) in THF (8.5 
mL) was added over 30 min to a suspension of magnesium 
powder (1.04 g, 42.6 mmol) in THF (4.2 mL). The temperature 
was kept below 30 °C (water bath). After stirring for 1.5 h, the 
mixture was filtered through a syringe filter and the flask was 
rinsed with THF (2 mL) to give a yellowish solution of 13 




Epoxide Opening: A suspension of copper(I) iodide (206 mg, 1.08 mmol, 20 mol%) in THF 
(30 mL) was cooled to −78 °C before an aliquot of the freshly prepared solution of the 
Grignard reagent 13 (0.80 M in THF, 10.2 mL, 8.12 mmol) was added dropwise. After stirring 
for 5 min, a solution of epoxide 12 (1.99 g, 5.41 mmol) in THF (30 mL) was added over 30 
min. Once the addition was complete, the mixture was stirred at −40°C for 50 min. The 
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reaction was quenched with sat. aq. ammonium chloride (60 mL) and the mixture was 
allowed to reach ambient temperature. The layers were separated and the aqueous phase was 
extracted with tert-butyl methyl ether (2 × 60 mL). The combined extracts were dried over 
Na2SO4, filtered and concentrated. The residue was purified by flash chromatography 
(hexanes/ethyl acetate, 5:1 to 2:1) to yield the title compound (2.35 g, 92%) as a pale yellow 
oil.  20D  = −2.6 (c = 0.52, CHCl3); 
1
H NMR (400 MHz, CDCl3): δ = 7.42 (d, J = 0.7 Hz, 1H), 
6.17 (dd, J = 1.0, 0.7 Hz, 1H), 5.16 (q, J = 6.7 Hz, 1H), 4.93 (t, J = 6.7 Hz, 1H), 4.83 (t, 
J = 4.7 Hz, 1H), 3.97-3.78 (m, 5H), 3.49 (d, J = 2.7 Hz, 1H), 3.23 (s, 3H), 1.93 (ddd, J = 13.9, 
9.1, 7.1 Hz, 1H), 1.59 (ddd, J = 13.9, 6.3, 2.7 Hz, 1H), 1.89 (d, J = 1.4 Hz, 3H), 1.68-1.43 (m, 
6H), 1.29 (d, J = 6.3 Hz, 3H), 0.9 (s, 9H), 0.1 (s, 3H), 0.01 (s, 3H); 13C NMR (100 MHz, 
CDCl3): δ = 160.3, 151.3, 145.4, 133.6, 113.3, 104.8, 75.0, 69.5, 68.4, 65.0 (2C), 56.7, 45.2, 
37.4, 34.0, 25.9 (3C), 20.3, 19.4, 18.2, 17.8, −4.5, −4.8; IR (film): ~  = 3487, 2950, 3930, 
2859, 1655, 1543, 1462, 1253, 1096, 970, 838, 778 cm
−1
; MS (ESI) m/z (%): 492 (M+Na
+
, 
100); HRMS (ESI): m/z: calcd. for C24H43NO6SiNa [M+Na
+




methylbut-1-en-1-yl)oxazole (S3). A solution of alcohol 14 
(2.35 g, 5.00 mmol) in CH2Cl2 (45 mL) was cooled to 0 °C 
before 2,6-lutidine (1.75 mL, 15.0 mmol) and TBDPSOTf 
(1.77 mL, 5.75 mmol) were successively added. After stirring 
for 20 min at 0 °C, the reaction was quenched with sat. aq. 
ammonium chloride (50 mL), the layers were separated and the 
aqueous phase was extracted with tert-butyl methyl ether (2 × 
50 mL). The combined extracts were dried over Na2SO4, filtered and concentrated. The 
residue was purified by flash chromatography (hexanes/ethyl acetate, 15:1 to 6:1) to obtain 
the title compound (3.11 g, 88%) as a colorless oil.  20D  = −9.0 (c = 0.25, CHCl3); 
1
H NMR 
(400 MHz, CDCl3): δ = 7.62 (td, J = 7.8, 1.3 Hz, 4H), 7.40-7.29 (m, 6H), 7.06 (s, 1H), 6.14 (s, 
1H), 5.21 (q, J = 6.2 Hz, 1H), 4.80 (t, J = 6.6 Hz, 1H), 4.67 (t, J = 4.1 Hz, 1H), 3.90-3.77 (m, 
5H), 3.17 (s, 3H), 2.01 (td, J = 6.8, 1.3 Hz, 2H), 1.88 (d, J = 1.4 Hz, 3H), 1.48-1.38 (m, 6H), 
1.27 (d, J = 6.2 Hz, 3H), 1.02 (s, 9H), 0.81 (s, 9H), 0.01 (s, 3H), 0.09 (s, 3H); 13C NMR (100 
MHz, CDCl3): δ = 159.6, 150.3, 144.9, 136.1 (2C), 136.0 (2C), 134.8, 134.6, 133.6, 129.6, 
129.57, 129.55, 127.55 (2C), 127.54 (2C), 113.7, 104.7, 74.9, 70.6, 65.8, 64.9, 56.5, 44.0, 
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36.6, 34.0, 27.3 (3C), 26.0 (3C), 19.6, 19.3, 19.1, 18.3, 17.7, −4.3, −4.6; IR (film): ~  = 2953, 
2931, 2887, 2852, 1428, 1257, 1107, 1066, 972, 939, 837, 820, 776, 702 cm
−1
; MS (ESI) m/z 
(%): 730 (M+Na
+







2,4,6-trimethylpyridine (1.10 mL, 8.31 mmol) and TMSOTf 
(1.00 mL, 5.54 mmol) were added to a solution of dioxolane 
S3 (2.21 g, 2.77 mmol) in CH2Cl2 (50 mL) at 0 °C. After 
stirring for 1 h at this temperature, water (50 mL) was added 
and stirring continued for 2 h at ambient temperature. The 
layers were separated and the aqueous phase was extracted 
with tert-butyl methyl ether (3 × 50 mL). The combined extracts were dried over Na2SO4, 
filtered and concentrated. The crude material was purified by flash chromatography 
(hexanes/ethyl acetate, 20:1 to 15:1) to give the title compound (1.78 g, 97%) as a pale yellow 
oil.  20D  = −10.4 (c = 0.50, CHCl3); 
1
H NMR (400 MHz, CDCl3): δ = 9.57 (t, J = 1.8 Hz, 
1H), 7.64-7.60 (m, 4H), 7.42-7.30 (m, 6H), 7.11 (s, 1H), 6.15 (qd, J = 1.4, 0.8 Hz, 1H), 5.20 
(q, J = 6.5 Hz, 1H), 4.79 (t, J = 6.5 Hz, 1H), 3.95-3.86 (m, 1H), 3.18 (s, 3H), 2.15-1.99 (m, 
4H), 1.89 (d, J = 1.4 Hz, 3H), 1.61-1.42 (m, 4H), 1.27 (d, J = 6.3 Hz, 3H), 1.04 (s, 9H), 0.81 
(s, 9H), 0.01 (s, 3H), 0.08 (s, 3H); 13C NMR (100 MHz, CDCl3): δ = 202.5, 160.0, 150.4, 
145.0, 136.1 (2C), 136.0 (2C), 134.6, 134.4, 133.6, 129.7 (2C), 127.62 (2C), 127. 61 (2C), 
113.6, 74.9, 70.1, 65.8, 56.6, 44.1, 43.8, 36.0, 27.2 (3C), 25.9 (3C), 19.6, 19.3, 18.2, 17.7, 
17.2, −4.3, −4.7; IR (film): ~  = 2953, 2930, 2891, 2857, 1727, 1655, 1589, 1544, 1472, 1462, 
1428, 1388, 1361, 1252, 1205, 1078, 1068, 1005, 971, 938, 836, 777 cm
−1
; MS (ESI) m/z (%): 
686 (M+Na
+
, 100); HRMS (ESI): m/z: calcd. for C38H57NO5Si2Na [M+Na
+








2-Butynal (18). Tetrabutylammonium chloride (3.97 g, 14.3 mmol, 0.10 equiv) and TEMPO 
(2.23, 14.3 mmol, 0.10 equiv) were added to a solution of 2-butyn-1-ol (10.0 g, 
143 mmol) in a mixture of CH2Cl2 (200 mL) and aq. carbonate buffer (100 mL 
0.5 M NaHCO3 and 100 mL 0.05 M K2CO3). N-Chlorosuccinimide (30.5 g, 228 mmol) was 
added in several portions,
5
 causing a slight exotherm and an evolution of gas, which was 
discharged by passing the gas stream through a wash bottle containing aq. sodium hydroxide 
solution (1 M). After stirring for 17 h, the aqueous phase was extracted with CH2Cl2 (4 × 75 
mL). The combined extracts were washed with brine, dried over Na2SO4 and filtered. The 
filtrate was purified by distillation (25 °C, ≤ 150 mbar, Vigreux column, the collection flask 
was cooled to −78 °C) to obtain the title compound (60% in CH2Cl2, 10.9 g, 67%) as a 
colorless solution. The compound is very sensitive and was kept under argon at −78 °C 
(decomposition commences with appearance of a pink coloration). The analytical data were in 




H NMR (400 MHz, CDCl3): δ = 9.15 (q, J = 
1.0 Hz, 1H), 2.07 (d, J = 0.9 Hz, 3H); 
13





 A solution of diisopropylamine (4.00 mL, 
28.5 mmol) in THF (60 mL) was cooled to 0 °C before it was treated 
dropwise with n-BuLi (1.6 M in hexanes, 16.2 mL, 25.9 mmol). After 
stirring for 5 min, tributyltin hydride (6.28 mL, 23.3 mmol) was added and stirring continued 
for 15 min at 0 °C. The resulting solution was then added over the course of 1 h to a solution 
of 3-chloro-2-chloromethyl-1-propene (3.00 mL, 25.9 mmol) in pentane (100 mL) at −78 °C. 
The mixture was stirred for 1 h at −78 °C before the reaction was quenched with water (100 
mL). The mixture was diluted with hexanes/ethyl acetate (10:1, 240 mL), the organic phase 
was washed with brine, dried over MgSO4, filtered and concentrated and the residue was 
purified by flash chromatography (hexanes) to yield the title compound (4.78 g, 49%) as a 





NMR (400 MHz, CDCl3): δ = 4.84 (dt, J = 1.3, 0.7 Hz, JH-Sn = 17.3 Hz, 1H), 4.71 (dt, J = 1.3, 
0.7 Hz, JH-Sn = 17.9 Hz, 1H), 3.96 (d, J = 0.9 Hz, JH-Sn = 5.8 Hz, 2H) 1.89 (d, J = 0.9 Hz, 
JH-Sn = 57.9 Hz, 2H), 1.60-1.36 (m, 6H), 1.36-1.22 (m, 6H), 0.95-0.79 (m, 15H); 
13
C NMR 
(100 MHz, CDCl3): δ = 145.8 (JH-Sn = 39.0 Hz), 110.0 (JH-Sn = 36.4 Hz), 50.4 (JH-Sn = 8.6 Hz), 
29.2 (JH-Sn = 20.1 Hz), 27.5 (JH-Sn
117
 = 54.0 Hz, JH-Sn
119
 = 56.0 Hz), 16.0 (JH-Sn
117





 = 231.3 Hz), 13.9, 9.8 (JH-Sn
117
 = 306.5 Hz, JH-Sn
119
 = 320.8 Hz); 
119
Sn NMR 
(150 MHz, CDCl3): δ = −12.9. 
 
(S)-2-(Chloromethyl)hept-1-en-5-yn-4-ol (19). Powdered molecular sieve 4 Å (5 g, 
activated for 5 days at 120 °C) and titanium(IV) isopropoxide (334 µL, 
1.13 mmol, 0.10 equiv) were added to a solution of (S)-(−)-1,1′-bi(2-
naphthol) (323 mg, 1.13 mmol, 0.10 mmol) in CH2Cl2 (25 mL). The 
orange suspension was stirred at reflux temperature for 1 h. After reaching 
ambient temperature, a solution of aldehyde 18 (75% in CH2Cl2, 1.02 g, 11.3 mmol) in 
CH2Cl2 (10 mL) was added. The mixture was cooled to −78 °C before stannane 17 (4.48 g, 
13.5 mmol) was added dropwise. After stirring for 3 d at −30 °C, TLC showed complete 
consumption of the starting material. The reaction was quenched with sat. aq. potassium 
sodium tartrate (50 mL) and stirring was continued for 1 h at room temperature. The 
suspension was filtered through a plug of Celite, which was carefully rinsed with tert-butyl 
methyl ether (25 mL). The volume of the filtrate was reduced, the layers were separated and 
the aqueous phase was extracted with tert-butyl methyl ether (2 × 25 mL). The combined 
extracts were dried over MgSO4, filtered and concentrated. The residue was purified by flash 
chromatography (hexanes/ethyl acetate, 10:1 to 4:1) to give the title compound (1.50 g, 84%) 
as a colorless liquid.  20D  = −28.7 (c = 1.05, CHCl3); 
1
H NMR (400 MHz, CDCl3): δ = 5.29 
(s, 1H), 5.13 (s, 1H), 4.54-4.50 (m, 1H), 4.13 (s, 2H), 2.58 (d, J = 6.7 Hz, 2H), 1.84 (d, J = 1.8 
Hz, 3H), 1.75 (br s, 1H); 
13
C NMR (100 MHz, CDCl3): δ = 141.2, 118.3, 81.9, 79.8, 61.4, 
48.5, 41.8, 3.7; IR (film): ~  = 3367, 2919, 2930, 1646, 1437, 1258, 1136, 1113, 1006, 913, 
851, 749 cm
−1
; MS (EI) m/z (%): 123 (2), 90 (3), 69 (100); HRMS (CI): m/z: calcd. for 
C8H15NO [M+NH4
+
]: 176.0842, found: 176.0840.  
The absolute configuration was determined by Mosher ester analysis, the ee was determined 
after the next step by HPLC on a chiral column. 
The other enantiomer, (R)-19, was obtained analogously using (R)-(−)-1,1′-bi(2-naphthol) as 
chiral ligand;  20D  = +25.8 (c = 1.08, CHCl3). 
 
(S)-2-(Chloromethyl)hept-1-en-5-yn-4-yl acetate (S4). 4-(Dimethylamino)pyridine (116 
mg, 0.946 mmol, 10 mol%), triethylamine (2.64 mL, 18.9 mmol) and 
acetic anhydride (1.34 mL, 14.2 mmol) were added to a solution of 
alcohol 19 (1.50 g, 9.46 mmol) in CH2Cl2 (60 mL). After stirring for 1 h, 
the mixture was carefully evaporated (40 °C, ≥ 600 mbar) and the residue was purified by 
S-13 
 
flash chromatography (pentane/Et2O 10:1) to furnish the title compound (1.77 g, 93%) as a 
colorless liquid. The enantiomeric purity (e.e. ≥ 95%) was determined by HPLC analysis on a 
chiral column (150 × 4.6 mm Chiralpak IC-3, 3 μm, n-heptane/2-propanol 99:1 (v/v), 1.0 
mL/min, 293 K).  20D  = −75.3 (c = 0.95, CHCl3); 
1
H NMR (400 MHz, CDCl3): δ = 5.51-5.48 
(ddq, J = 8.4 6.4, 2.2 Hz, 1H), 5.25 (d, J = 1.1 Hz, 1H), 5.08 (d, J = 1.1 Hz, 1H), 4.10 (d, J = 
11.8 Hz, 1H), 4.08 (d, J = 11.8 Hz, 1H), 2.70-2.57 (m, 2H), 2.06 (s, 3H), 1.83 (d, J = 2.2 Hz, 
3H); 
13
C NMR (100 MHz, CDCl3): δ = 170.1, 140.3, 118.6, 82.7, 76.3, 62.9, 48.2, 38.8, 21.2, 
3.7; IR (film): ~  = 2930, 2923, 1739, 1647, 1437, 1371, 1230, 1160, 1020, 989, 914, 752 
cm
−1
; MS (ESI) m/z (%): 223 (M+Na
+
, 100); HRMS (ESI): m/z: calcd. for C10H13O2ClNa 
[M+Na
+
]: 223.0496, found: 223.0494. 
 
(S)-2-(Iodomethyl)hept-1-en-5-yn-4-yl acetate (S5). Sodium iodide (2.19 g, 14.6 mmol) 
was added to a solution of chloride S4 (2.18 g, 10.8 mmol) in acetone (15 
mL) and the resulting suspension was stirred at reflux temperature for 20 
h. After cooling to ambient temperature, the excess reagent was quenched 
with sat. aq. sodium thiosulfate (25 mL) and the layers were separated. The aqueous phase 
was extracted with ethyl acetate (3 × 25 mL), and the combined extracts were dried over 
Mg2SO4, filtered and concentrated (40 °C, ≥150 mbar). The crude material was purified by 
flash chromatography (pentane/Et2O, 20:1 to 10:1) to yield the title compound (2.78 g, 88%) 
as a pale yellow liquid.  20D  = −38.9 (c = 1.10, CHCl3); 
1
H NMR (400 MHz, CDCl3): δ = 
5.50-5.49 (m, 1H), 5.35 (d, J = 0.8 Hz,1H), 5.01 (d, J = 0.8 Hz, 1H), 4.01 (dd, J = 9.6, 0.4 Hz, 
1H), 3.97 (d, J = 9.6 Hz, 1H), 2.71 (ddd, J = 14.4, 6.1, 0.8 Hz, 1H), 2.63 (ddd, J = 14.4, 7.1, 
0.8 Hz, 1H), 2.06 (s, 3H), 1.83 (d, J = 2.2 Hz, 3H); 
13
C NMR (100 MHz, CDCl3): δ = 170.1, 
141.8, 117.7, 82.7, 76.3, 62.9, 39.8, 21.2, 10.4, 3.8; IR (film): ~  = 2956, 2920,1739, 1636, 
1431, 1371, 1230, 1157, 1020, 986, 914 cm
−1
; MS (EI) m/z (%): 232 (72), 123 (47), 105 
(100); HRMS (ESI): m/z: calcd. for C10H13O2INa [M+Na
+
]: 314.9852, found: 314.9852. 
 
(S)-2-((Tributylstannyl)methyl)hept-1-en-5-yn-4-yl acetate (20). Hexabutylditin (5.53 mL, 
10.9 mmol) and tris-(dibenzylideneacetone)-dipalladium(0) (110 mg, 
0.12 mmol, 1.7 mol%) were added to a suspension of iodide S5 (2.13 
g, 7.29 mmol) in THF (10 mL). Argon was bubbled through the 
green-black suspension for 30 min, before the mixture was stirred for 3 h at 55 °C. Because 
TLC showed unreacted starting material, the same amount of tris-(dibenzylideneacetone)-
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dipalladium(0) (1.7 mol%) was added. Stirring at reflux temperature was continued for an 
additional 1.5 h before the reaction was quenched with sat. aq. NaHCO3 (25 mL). The mixture 
was filtered through a plug of Celite which was rinsed with tert-butyl methyl ether (2 x 25 
mL). The layers were separated and the aqueous phase was extracted with tert-butyl methyl 
ether (3 x 25 mL). The combined extracts were dried over Na2SO4, filtered and concentrated. 
The residue was purified by repeated flash chromatography (hexanes + 2% triethylamine) to 
yield the title compound (2.42 g, 73%) as a colorless liquid.  20D  = −28.1 (c = 0.98, CHCl3); 
1
H NMR (400 MHz, CDCl3): δ = 5.49 (t, J = 7.2 Hz, 1H), 4.64-4.61(m, 1H), 4.55-4.53 (m, 
1H), 2.35 (dd, J = 14.1, 7.3 Hz, 1H), 2.31 (dd, J = 14.1, 6.2 Hz, 1H), 2.06 (s, 3H), 1.84 (d, J = 
1.6 Hz, 3H), 1.80 (s, 2H), 1.56-1.39 (m, 6H), 1.30 (sext, J = 7.2 Hz, 6H), 0.89 (t, J = 7.7 Hz, 
9H), 0.87 (t, J = 7.2 Hz, 6H); 
13
C NMR (100 MHz, CDCl3): δ = 170.5, 144.6, 108.4, 82.2, 
77.1, 63.3, 44.0, 29.3 (JH-Sn = 10.1 Hz, 3C), 27.5 (JH-Sn
117
 = 26.9 Hz, JH-Sn
119
 = 28.1 Hz, 3C), 
21.3, 19.1, 13.9 (3C), 9.6 (JH-Sn
117
 = 151.6 Hz, JH-Sn
119
 = 158.7 Hz, 3C), 3.9; IR (film): ~  = 
2956, 2923, 2853, 2872, 2742, 1629, 1464, 1371, 1230, 1018, 961, 866 cm
−1
; MS (EI) m/z 
(%): 456 (2), 399 (13), 179 (100), 57 (45), 43 (29); HRMS (ESI): m/z: calcd. for 
C22H40O2SnNa [M+Na
+
]: 479.1956, found: 479.1954. 






 Sodium iodide (20.0 g, 133 
mmol) was added to a solution of the (R)-3-bromo-2-methylpropan-1-ol 24 
(5.00 g, 32.6 mmol) in acetone (60 mL). The mixture was stirred at reflux 
temperature for 18 h. Water (20 mL) was added and the acetone was removed under reduced 
pressure and the resulting mixture was extracted with CH2Cl2 (2 x 30 mL). The combined 
extracts were washed with aq. sat. ammonium thiosulfate (2 x 30 mL) and brine, dried over 
Na2SO4, filtered and concentrated. The resulting crude product was directly used in the next 
step. 
Imidazole (2.40 g, 35.8 mmol) and TBSCl (5.40 g, 35.8 mmol) were added at 0 
o
C to a 
solution of crude (R)-3-iodo-2-methylpropan-1-ol described above (6.30 g, 32.6 mmol) in 
CH2Cl2 (100 mL). The mixture was stirred for 3 h at 0 °C, before it was filtered and washed 
with pentane (50 mL). The combined filtrates were evaporated, the residue was suspended in 
pentane and the resulting mixture filtered again through Celite, rinsing with pentane. The 
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combined filtrate was evaporated and the residue purified by flash chromatography (hexane) 
to give the title compound (8.54 g, 85%) as a colorless oil.  20D  = −10.5 (c = 4.14, CHCl3); 
1
H NMR (400 MHz, CDCl3): δ = 3.52 (dd, J = 10.1, 4.9 Hz, 1H), 3.39 (dd, J = 10.1, 6.7 Hz, 
1H), 3.30 (dd, J = 9.6, 5.2 Hz, 1H), 3.24 (dd, J = 9.6, 5.4 Hz, 1H), 1.67-1.59 (m, 1H), 0.95 (d, 
J = 6.6 Hz, 3H), 0.89 (s, 9H), 0.060 (s, 3H), 0.059 (s, 3H); 
13
C NMR (100 MHz, CDCl3): δ = 
66.9, 37.6, 26.1, 18.5, 17.5, 13.9, 5.1 (2C); IR (film): ~  = 2955, 2929, 2894, 2857, 1470, 
1475, 1419, 1386, 1361, 1329, 1251, 1197, 1181, 1136, 1098, 1065, 1035, 1006, 937, 835, 
773 cm
−1
; MS (EI) m/z (%): 257 (100); HRMS (CI): m/z: calcd. for C10H24OISi [M
+
+H]: 





 n-BuLi (1.6 M in hexanes, 
48.8 mL, 78.1 mmol) was added dropwise at −78 oC to a 
stirred suspension of lithium chloride (flame-dried, 12.8 g, 
308 mmol) and diisopropylamine (11.8 mL, 84.0 mmol) in THF (48 mL). The mixture was 
warmed to 0 
o
C for 5 min before it was cooled again to −78 oC. A solution of (R,R)-(−)-
pseudoephedrine propionamide 26 (8.0 g, 36.9 mmol)
 
in THF (102 mL) was added dropwise 
and the resulting mixture was stirred for 1 h at −78 oC, 30 min at 0 oC and 5 min at ambient 
temperature. A solution of 25 (7.2 g, 22.8 mmol) in THF (10 mL) was added dropwise at 0 
o
C 
and stirring continued for 22 h at room temperature. The reaction was quenched with aq. sat. 
ammonium chloride (100 mL) and the aqueous phase was extracted with ethyl acetate (2 x 
100 mL). The combined extracts were washed with brine, dried over Na2SO4 filtered and 
concentrated. The remaining residue was purified by flash chromatography (hexanes/ethyl 
acetate, 3:1) to give the title compound as a colorless solid (9.1 g, 98%) (mixture of rotamers, 
3:1, NMR).  20D  = −53.0 (c = 1.5, CHCl3); 
1
H NMR (400 MHz, CDCl3) (major rotamer): δ = 
7.35-7.29 (m, 5H), 3.60 (t, J = 7.2 Hz, 1H), 4.42 (br s, 1H), 3.39 (dd, J = 9.7, 5.2 Hz, 1H), 
3.31 (dd, J = 9.7, 6.1 Hz, 1H), 2.85 (s, 3H), 2.71 (q, J = 7.0 Hz, 1H), 1.74 (oct, J = 6.5 Hz, 
1H), 1.41-1.37 (m, 2H), 1.12 (d, J = 7.2 Hz, 3H), 1.06 (d, J = 6.8 Hz, 3H), 0.88 (s, 9H), 0.84 
(d, J = 6.6 Hz, 3H), 0.020 (s, 3H), 0.018 (s, 3H); 
13
C NMR (100 MHz, CDCl3) (major 
rotamer): δ = 179.5, 142.8, 128.4 (2C), 127.7, 126.5 (2C), 76.7, 68.5 (2C), 37.6, 34.6, 33.7, 
26.1 (3C), 18.6, 17.4, 17.1, 14.6, −5.2 (2C) (one carbon is missing due to signal overlap); IR 
(film): ~  = 3374, 2955, 2930, 2857, 1620, 1471, 1461, 1408, 1251, 1087, 835, 774, 701 
cm
−1
; MS (EI) m/z (%): 392 (3), 350 (56), 300 (16), 243 (100); HRMS (ESI): m/z: calcd. for 
C23H41NO3SiNa [M+Na
+




(2S,4S)-5-((tert-Butyldimethylsilyl)oxy)-2,4-dimethylpentan-1-ol (S6). n-BuLi (1.6 M in 
hexanes, 55.8 mL, 89.2 mmol) was added at −78 oC over 15 min to a 
stirred solution of diisopropylamine (13.3 mL, 95.5 mmol) in THF 
(92 mL). The mixture was stirred at this temperature for 10 min and for another 10 min at 0 
o
C. Borane-ammonia complex (90%, 3.10 g, 100 mmol) was then added and stirring 
continued for 15 min at 0 
o
C and for additional 15 min at ambient temperature. The mixture 
was cooled to 0 
o
C before a solution of amide 27 (9.00 g, 22.3 mmol) in THF (160 mL) was 
added over 15 min. Stirring was continued for 2 h at ambient temperature before the excess 
reagent was quenched at 0°C with aq. sat. ammonium chloride (150 mL). The aquous layer 
was extracted with tert-butyl methyl ether (3 × 100 mL) and the combined extracts were 
washed with brine (30 mL), dried over Na2SO4, filtered and evaporated. The residue was 
purified by flash chromatography (hexanes/ethyl acetate, 10:1) to obtain the title compound as 
a colorless syrup (4.90 g, 89%).  20D  = −24.7 (c = 1.59, CHCl3); 
1
H NMR (400 MHz, 
CDCl3) δ = 3.5-3.42 (m, 2H), 3.40 (dd, J = 6.3, 1.8 Hz, 2H), 1.78-1.67 (m, 2H), 1.47 (t, J = 
5.9 Hz, 1H), 1.21 (ddd, J = 13.6, 8.8, 4.8 Hz, 1H), 1.12 (ddd, J = 13.6, 8.8, 4.8 Hz, 1H), 0.89 
(s, 9H), 0.89 (d, J = 6.8 Hz, 3H), 0.85 (d, J = 6.7 Hz, 3H), 0.04 (s, 6H); 
13
C NMR (100 MHz, 
CDCl3): δ = 69.3, 69.2, 37.0, 33.3, 33.1, 26.2 (3C), 18.5, 16.8, 16.7, −5.1 (2C); IR (film): 
~  = 
3375, 2954, 2929, 2857, 1620, 1471, 1454, 1405, 1095, 1050, 836, 774, 701 cm
−1
; MS (EI) 
m/z (%): 215 (1), 189 (1), 55 (100); HRMS (CI): m/z: calcd. for C13H31NO2Si [M+H
+
]: 
247.2093 found: 247.2093. 
 
((2S,4S)-5-((tert-Butyldimethylsilyl)oxy)-2,4-dimethylpentanal (28). A suspension of N-
methylmorpholine-N-oxide monohydrate (1.41 g, 10.4 mmol) and 
powdered molecular sieves (4 Å, 4 g) in CH2Cl2 (66 mL) was stirred 
for 10 min before a solution of alcohol S6 (2.00 g, 8.1 mmol) in CH2Cl2 (32 mL) and tetra-N-
propylammonium perruthenate (140 mg, 0.39 mmol, 5 mol%) were successively added. The 
resulting mixture was stirred for 30 min before it was filtered through a pad of Celite, which 
was carefully rinsed with CH2Cl2 (50 mL). The combined filtrates were evaporated and the 
residue was purified by a flash chromatography (hexanes/ethyl acetate, 5:1) to yield the title 
compound (1.72 g, 88%), which was immediately used in the next reaction. The recorded 




H NMR (400 MHz, 
CDCl3) δ = 9.59 (d, J = 2.0 Hz, 1H), 3.43 (dd, J = 9.8, 6.0 Hz, 1H), 3.39 (dd, J = 9.8, 6.0 Hz, 
1H), 2.45-2.36 (m, 1H), 1.71-1.63 (m, 1H), 1.47 (ddd, J = 13.7, 8.3, 6.0 Hz, 1H), 1.39 (ddd, J 
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= 13.7, 8.3, 5.7 Hz, 1H), 1.04 (d, J = 6.8 Hz, 3H), 0.86 (s, 9H), 0.85 (d, J = 6.6 Hz, 3H), 0.01 
(s, 6H); 
13
C NMR (100 MHz, CDCl3): δ = 205.3, 68.2, 44.2, 34.0, 33.3, 26.0 (3C), 18.3, 16.6, 
13.5, −5.3 (2C). 
 
tert-Butyl(((2S,4S)-6,6-dibromo-2,4-dimethylhex-5-en-1-yl)oxy)dimethylsilane (29). Zinc 
powder (835 mg, 12.8 mmol) and triphenylphosphine (3.43 g, 13.1 
mmol) were added to a solution of tetrabromomethane (4.34 g, 
13.1 mmol) in CH2Cl2 (70 mL). After stirring for 18 h, a solution of aldehyde 28 (1.60 g, 6.54 
mmol) in CH2Cl2 (20 mL) was slowly added and stirring was continued for 5 h. The mixture 
was poured into a beaker containing hexanes and the resulting precipitate was filtered off. 
Evaporation of the filtrate and purification of the residue by flash chroamtography 
(hexanes/ethyl acetate, 5:1) gave the title compound as a colorless syrup (1.93 g, 74%).  20D  
= +4.2 (c = 1.00, CHCl3); 
1
H NMR (400 MHz, CDCl3) δ = 6.19 (d, J = 8.9 Hz, 1H), 3.44 (dd, 
J = 9.8, 5.4 Hz, 1H), 3.40 (dd, J = 9.8, 5.9 Hz, 1H), 2.56-2.48 (m, 1H), 1.69-1.53 (m, 1H), 
1.42 (dt, J = 13.5, 6.8 Hz, 1H), 1.12 (dt, J = 14.7, 7.3 Hz, 1H), 0.98 (d, J = 6.8 Hz, 3H), 0.90 
(s, 9H), 0.89 (d, J = 6.7 Hz, 3H), 0.04 (s, 6H); 
13
C NMR (100 MHz, CDCl3): δ = 144.9, 87.2, 
67.8, 39.6, 36.2, 33.6, 26.2 (3C), 19.4, 18.5, 17.4, −5.1 (2C); IR (film): ~  = 2956, 2929, 
2827, 1471, 1461, 1251, 1095, 1080, 1006, 836, 774, 667 cm
−1
; MS (EI) m/z (%): 343 (45), 
107 (100); HRMS (CI): m/z: calcd. for C14H29OBrSi [M+H
+
]: 399.0354 found: 399.0350. 
 
tert-Butyl(((2S,4S)-2,4-dimethylhept-5-yn-1-yl)oxy)dimethylsilane (S7). n-BuLi (1.6 M in 
hexanes, 6.93 mL, 11.1 mmol) was added at −78 oC to a solution of 
dibromo-olefin 29 (1.93 g, 4.82 mmol) in THF (18 mL). The 
mixture was stirred at this temperature for 1 h and for 1 h at 23 °C. 
Iodomethane (0.81 mL, 13.0 mmo) was introduced and stirring continued for 2.5 h. The 
reaction was quenched with aq. sat. ammonium chloride (20 mL) and the aqueous phase was 
extracted with Et2O (2 x 20 mL). The combined extracts were washed with brine (10 mL) and 
dried over Na2SO4, filtered and concentrated under vacuum. The residue was purified by flash 
chromatography (hexane to hexanes/ethyl acetate, 10:1) to obtain the title compound as a 
colorless oil (1.19 g, 97%, d.r. ≥ 95:5).  20D  = +24.7 (c = 1.05, CHCl3); 
1
H NMR (400 MHz, 
CDCl3) δ = 3.48 (dd, J = 9.7, 5.2 Hz, 1H), 3.39 (dd, J = 9.7, 6.2 Hz, 1H), 2.48-2.39 (m, 1H), 
1.48-1.76 (m, 1H), 1.78 (d, J = 2.4 Hz, 3H), 1.41 (ddd, J = 13,4, 7.1, 6.7 Hz, 1H), 1.23 (ddd, J 
= 14,7, 8.7, 6.6 Hz, 1H), 1.10 (d, J = 6.8 Hz, 3H), 0.90 (d, J = 6.7 Hz, 3H), 0.89 (s, 9H), 0.03 
(s, 6H); 
13
C NMR (100 MHz, CDCl3): δ = 84.4, 75.5, 67.7, 41.2, 33.8, 26.1 (3C), 23.9, 21.8, 
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18.5, 17.6, 3.7, −5.2, −5.1; IR (film): ~  = 2956, 2929, 2857, 1471, 1388, 1361, 1251, 1092, 
1019, 1006, 939, 835, 773, 666 cm
−1
; MS (EI) m/z (%): 197 (13), 75 (100); HRMS (CI): m/z: 
calcd. for C15H31OSi [M+H
+
]: 255.2144 found: 255.2144. 
 
(2S,4S)-2,4-Dimethylhept-5-yn-1-ol (S8). Tetrabutylammonium fluorode (1 M in THF, 8.17 
mL, 8.17 mmol) was added to a solution of alkyne S7 (1.04 g, 4.09 
mmol) in THF (6.0 mL). The mixture was stirred for 18 h before the 
reaction was quenched with aq. sat. ammonium chloride (5 mL) and 
extracted with tert-butyl methyl ether (2 x 10 mL). The combined extracts were washed with 
brine (10 mL), dried over Na2SO4, filtered and concentrated. The remaining crude material 
was purified by flash chromatography (hexanes/ethyl acetate, 5:1) to yield S8 as a colorless 
liquid (550 mg, 3.92 mmol, 96%, d.r. ≥ 95:5).  20D  = +24.4 (c = 1.04, CHCl3); 
1
H NMR (400 
MHz, CDCl3) δ = 3.53 (dd, J = 10.5, 5.5 Hz, 1H), 3.42 (dd, J = 10.5, 6.0 Hz, 1H), 2.49-2.42 
(m, 1H), 1.84 (oct, J = 6.5 Hz, 1H), 1.75 (d, J = 2.5 Hz, 3H), 1.72 (br s, 1H), 1.39 (ddd, J = 
13,4, 7.2, 6.1, 1H), 1.30 (ddd, J = 14,9, 8.6, 6.2, 1H), 1.10 (d, J = 6.7 Hz, 3H), 0.92 (d, J = 7.2 
Hz, 3H); 
13
C NMR (100 MHz, CDCl3): δ = 84.1, 75.9, 67.7, 41.1, 33.7, 23.6, 21.7, 17.4, 3.6; 
IR (film): ~  = 3323, 2960, 2921, 2873, 1453, 1375, 1043, 999, 977, 943, 757, 667 cm−1; MS 





(2S,4S)-2,4-Dimethylhept-5-ynoic acid (30). Tetra-n-propylammonium perruthenate (96.5 
mg, 275 µmol, 10 mol%) was added to a solution of N-
methylmorpholine-N-oxide monohydrate (3.22 g, 27.5 mmol) and 
alcohol S8 (385 mg, 2.75 mmol) in MeCN (5.6 mL). After stirring for 
45 min, the mixture was filtered through a pad of Celite, which was carefully rinsed with 
ethyl acetate (10 mL). The combined filtrates were evaporated and the crude product was 
purified by flash chromatography (hexanes/ethyl acetate, 8:1) to give the title compound as a 
colorless liquid (391 mg, 92%, d.r. ≥ 95:5).  20D  = +108.2 (c = 0.55, CHCl3); 
1
H NMR (400 
MHz, CDCl3) δ = 2.82-2.73 (m, 1H), 2.52-2.43 (m, 1H), 1.78 (ddd, J = 14,8, 9.8, 4.8 Hz, 1H), 
1.77 (d, J = 2.33 Hz, 3H), 1.13 (ddd, J = 14,8, 10.4, 4.5 Hz, 1H), 1.23 (d, J = 6.8 Hz, 3H), 
1.14 (d, J = 7.1 Hz, 3H); 
13
C NMR (100 MHz, CDCl3): δ = 182.9, 82.9, 76.7, 41.2, 37.9, 24.6, 
21.9, 18.2, 3.67; IR (film): ~  = 3100, 2972, 2921, 1706, 1456, 1377, 1248, 945 cm−1; MS 
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(EI) m/z (%): 154 (1), 109 (26), 98 (100), 74 (37), 45 (7); HRMS (EI): m/z: calcd. for C9H14O2 
[M
+
]: 154.0993, found: 154.0993. 
 




oxazol-4-yl)-6-methylenetetradec-2-yn-4-yl acetate (22). 
Boron tribromide (1 M in CH2Cl2, 3.39 mL, 3.39 mmol) was 
added at 0 °C to a solution of (S,S)-1,2-diphenyl-1,2-
ethylenediamine bis(toluenesulfonamide) (1.76 g, 3.39 
mmol)
12
 in CH2Cl2 (40 mL). The mixture was stirred for 10 
min at 0 °C and for 1 h at ambient temperature before all 
volatile materials were removed in high vacuum.  
Allyl stannane 20 (1.80 g, 3.95 mmol) was added dropwise at 
0 °C to a solution of the residue in CH2Cl2 (40 mL). After 
stirring for 17 h at ambient temperature, the mixture was cooled to −78°C and a solution of 
aldehyde 15 (1.50 g, 2.26 mmol) in CH2Cl2 (10 mL) was added dropwise over 5 min. The 
mixture was stirred for 2 h before the reaction was quenched with aq. phosphate buffer (pH 7, 
50 mL). Water (50 mL) was introduced and the aqueous phase was extracted with CH2Cl2 (3 
× 100 mL). The combined extracts were washed with brine (150 mL), dried over MgSO4, 
filtered and concentrated. The residue was suspended in Et2O (20 mL) and the colorless solid 
was filtered off to recover the chiral diamine ligand. The filtrate was evaporated and the 
residue was purified by flash chromatography (hexanes/ethyl acetate, 10:1 to 3:1) to give the 
title compound (1.79 g, 95%, d.r. > 10:1) as a colorless oil.  20D  = −20.9 (c = 1.00, CHCl3). 
1
H NMR (600 MHz, CDCl3) δ = 7.62 (m, 2H), 7.59 (m, 2H), 7.37 (m, 1H), 7.36 (m, 1H), 7.31 
(m, 2H), 7.29 (m, 2H), 7.08 (d, J = 0.5 Hz, 1H), 6.14 (qd, J = 1.4, 1.0 Hz, 1H), 5.45 (ddq, J = 
7.8, 6.0, 2.2 Hz, 1H), 5.19 (qd, J = 6.5, 0.8 Hz, 1H), 4.95 (dt, J = 1.4, 1.2 Hz, 1H), 4.90 (d, 
J = 1.1 Hz, 1H), 4.81 (td, J = 6.7, 0.7 Hz, 1H), 3.84 (tdd, J = 6.2, 5.8, 5.1 Hz, 1H), 3.52 (dddt, 
J = 9.4, 7.6, 4.4, 3.2 Hz, 1H), 3.15 (s, 3H), 2.45 (ddd, J = 14.4, 7.8, 0.8 Hz, 1H), 2.40 (ddd, 
J = 14.4, 6.0, 0.9 Hz, 1H), 2.14 (ddd, J = 14.3, 3.3, 1.2 Hz, 1H), 2.03 (s, 3H), 2.01 (t, 
J = 6.7 Hz, 2H), 1.95 (ddd, J = 14.3, 9.4, 0.5 Hz, 1H), 1.86 (d J = 1.5 Hz, 3H), 1.82 (d, 
J = 2.2 Hz, 3H), 1.63 (d, J = 3.1 Hz, 1H), 1.47 (m, 1H), 1.38 (m, 1H), 1.32 (m, 1H), 1.26 (d, J 
= 6.5 Hz, 3H), 1.24 (m, 1H), 1.20 (m, 1H), 1.15 (m, 1H), 1.01 (s, 9H), 0.80 (s, 9H), 0.00 (s, 
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3H), −0.09 (s, 3H); 13C NMR (150 MHz, CDCl3): δ = 170.0, 159.8, 150.1, 144.7, 141.3, 
135.90 (2C), 135.87 (2C), 134.6, 134.3, 133.5, 129.5, 129.4, 127.41 (2C), 127.39 (2C), 116.1, 
113.5, 82.2, 76.5, 74.7, 70.4, 68.8, 65.6, 62.8, 56.4, 44.3, 44.0, 41.6, 37.2, 36.7, 27.1 (3C), 
25.8 (3C), 21.0, 20.7, 19.4, 19.2, 18.1, 17.5, 17.5, 3.6, −4.5, −4.8; IR (film): ~  = 3479, 2929, 
2857, 1740, 1428, 1371, 1233, 1109, 837, 777, 703, 507 cm
−1
; MS (ESI) m/z (%): 852 
(M+Na
+
, 100); HRMS (ESI): m/z: calcd. for C48H71NO7Si2Na [M+Na
+






dec-2-yn-4-yl acetate (S9). 2,2,2-Trichlorethoxycarbonyl 
chloride (0.89 mL, 6.45 mmol) was added at 0 °C to a solution 
of alcohol 22 (1.79 g, 2.15 mmol), 4-(dimethylamino)pyridine 
(26.3 mg, 215 µmol, 0.10 equiv) and pyridine (1.04 mL, 12.9 
mmol) in CH2Cl2 (20 mL). After stirring for 20 min at 
ambient temperature, the reaction was quenched with water 
(20 mL) and the aqueous phase was extracted with ethyl 
acetate (3 × 25 mL). The combined extracts were dried over 
MgSO4, filtered and concentrated, and the residue was 
purified by flash chromatography (hexanes/ethyl acetate, 10:1) to give the title compound 
(2.15 g, quant.) as a colorless oil.  20D  = −21.0 (c = 1.00, CHCl3); 
1
H NMR (600 MHz, 
CDCl3) δ = 7.61 (m, 2H), 7.59 (m, 2H), 7.38 (m, 1H), 7.37 (m, 1H), 7.32 (m, 2H), 7.30 (m, 
2H), 7.08 (d, J = 0.6 Hz, 1H), 6.14 (qd, J = 1.4, 1.0 Hz, 1H), 5.41 (tq, J = 6.9, 2.2 Hz, 1H), 
5.18 (qd, J = 6.5, 0.7 Hz, 1H), 4.89 (dt, J = 1.3 Hz + not resolved, 1H), 4.88 (dt, J = 1.3 Hz + 
not resolved, 1H), 4.78 (t, J = 6.7 Hz, 1H), 4.75 (m, 1H), 4.74 (d, J = 11.9 Hz, 1H), 4.64 (d, J 
= 11.9 Hz, 1H), 3.84 (tt, J = 6.2, 5.4 Hz, 1H), 3.16 (s, 3H), 2.44 (d, J = 6.9 Hz, 2H), 2.26 
(ddd, J = 14.6, 8.2, 0.7 Hz, 1H), 2.22 (ddd, J = 14.6, 5.0, 0.9 Hz, 1H), 2.02 (s, 3H), 2.00 (dt, J 
= 13.7, 6.7 Hz, 1H), 1.94 (dt, J = 13.7, 6.4 Hz, 1H), 1.87 (d, J = 1.4 Hz, 3H), 1.80 (d, J = 2.2 
Hz, 3H), 1.46 (m, 1H), 1.39 (m, 1H), 1.36 (m, 1H), 1.29 (m, 2H), 1.25 (d, J = 6.5 Hz, 3H), 
1.24 (m, 1H), 1.01 (s, 9H), 0.79 (s, 9H), 0.00 (s, 3H), −0.10 (s, 3H); 13C NMR (150 MHz, 
CDCl3): δ = 169.9, 159.8, 153.7, 150.2, 144.8, 139.4, 135.90 (2C), 135.84 (2C), 134.5, 134.2, 
133.5, 129.5 (2C), 127.44 (2C), 127.43 (2C), 117.1, 113.5, 94.6, 82.1, 77.9, 76.53, 76.50, 
74.7, 70.2, 65.6, 62.7, 56.4, 44.0, 41.4, 40.9, 36.4, 34.1, 27.1 (3C), 25.8 (3C), 21.0, 20.3, 19.4, 
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19.2, 18.1, 17.5, 3.6, −4.5, −4.9; IR (film): ~  = 2954, 2930, 2857, 1755, 1378, 1250, 1110, 
836, 821, 704, 507 cm
−1
; MS (ESI) m/z (%): 1028 (M+Na
+
, 100); HRMS (ESI): m/z: calcd. 
for C51H72NO9Cl3Si2Na [M+Na
+





(23). 10-Camphorsulfonic acid (102 mg, 0.438 mmol, 10 
mol%) was added to a solution of compound S9 (2.20 g, 2.19 
mmol) in CH2Cl2/MeOH (24 mL/8mL). After stirring for 8 h, 
TLC control indicated that the acetate started to get cleaved. 
At this point the mixture was neutralized with aq. sat. 
NaHCO3 (40 mL). The aqueous phase was extracted with tert-
butyl methyl ether (3 × 25 mL) and the combined extracts 
were dried over MgSO4, filtered and concentrated. The 
residue was purified by flash chromatography (hexanes/ethyl acetate, 10:1 to 2:1) to give 
unreacted starting material (823 mg, 37%) and the desired product 23 (1.19 g, 61%, 98% 
brsm).  20D  = −2.6 (c = 1.15, CHCl3). 
1
H NMR (600 MHz, CDCl3) δ = 7.67 (m, 2H), 7.67 
(m, 2H), 7.42 (m, 1H), 7.42 (m, 1H), 7.36 (m, 4H), 7.26 (d, J = 1.0 Hz, 1H), 6.15 (qd, J = 1.4, 
1.0 Hz, 1H), 5.40 (tq, J = 6.9, 2.2 Hz, 1H), 5.10 (qd, J = 6.5, 0.8 Hz, 1H), 4.88 (dt, J = 1.3, 1.1 
Hz, 1H), 4.86 (dt, J = 1.2 Hz + not resolved, 1H), 4.82 (dtd, J = 8.9, 3.8, 0.9 Hz, 1H), 4.72 (d, 
J = 11.9 Hz, 1H), 4.71 (m, 1H), 4.65 (d, J = 11.9 Hz, 1H), 4.00 (tt, J = 7.2, 4.7 Hz, 1H), 3.18 
(s, 3H), 3.06 (d, J = 3.8 Hz, 1H), 2.43 (dt, J = 6.9, 1.1 Hz, 2H), 2.25 (ddd, J  = 14.5, 8.2, 0.6 
Hz, 1H), 2.19 (ddd, J = 14.5, 4.8, 0.8 Hz, 1H), 2.02 (s, 3H), 1.99 (ddd, J = 14.2, 4.7, 3.9 Hz, 
1H), 1.90 (ddd, J = 14.3, 8.8, 7.7 Hz, 1H), 1.86 (d, J = 1.4 Hz, 3H), 1.80 (d, J = 2.2 Hz, 3H), 
1.45 (m, 1H), 1.33 (m, H), 1.31 (m, 1H) 1.27 (d, J = 6.5 Hz, 3H), 1.20 (m, 3H), 1.04 (s, 9H); 
13
C NMR (150 MHz, CDCl3): δ = 169.9, 160.4, 153.7, 150.5, 144.3, 139.3, 135.88 (2C), 
135.87 (2C), 134.1, 133.5, 133.0, 129.9, 129.8, 127.7 (2C), 127.6 (2C), 117.1, 113.5, 94.6, 
82.2, 77.7, 76.53, 76.46, 74.7, 72.8, 66.2, 62.7, 56.4, 42.6, 41.4, 40.9, 36.8, 33.9, 27.0 (3C), 
21.0, 20.5, 19.29, 19.26, 17.6, 3.6; IR (film): ~  = 3422, 2932, 2858, 1754, 1652, 1428, 1378, 
1250, 1109, 1067, 1021, 821, 735, 704, 612, 508 cm
−1
; MS (ESI) m/z (%): 914 (M+Na
+
, 100); 
HRMS (ESI): m/z: calcd. for C45H58NO9Cl3SiNa [M+Na
+







2,4-dimethylhept-5-ynoate (31). 2,4,6-Trichlorobenzoyl 
chloride (413 µL, 2.64 mmol)
13
 and triethylamine (368 µL, 
2.64 mmol) were added at 0 °C to a solution of acid 30 (299 
mg, 1.94 mmol) in toluene (25 mL). The mixture was stirred 
at ambient temperature for 1 h. After cooling to 0 °C, a 
solution of alcohol 23 (1.57 g, 1.76 mmol) in toluene (20 mL) 
and 4-(dimethylamino)pyridine (215 mg, 1.76 mmol) were 
successively added. Stirring was continued for 1 h before the 
mixture was diluted with ethyl acetate (30 mL) and the 
reaction was quenched with hydrochloric acid (1 M, 80 mL). The aqueous phase was extracted 
with ethyl acetate (2 × 80 mL) and the combined extracts were dried over MgSO4, filtered and 
concentrated. The residue was purified by flash chromatography (hexanes/ethyl acetate, 10:1 
to 4:1) to yield the title compound as a colorless syrup (1.81 g, quant.).  20D  = −7.4 (c = 1.00, 
CHCl3); 
1
H NMR (400 MHz, CDCl3): δ = 7.64-7.57 (m, 4H), 7.44-7.29 (m, 6H), 7.19 (br s, 
1H), 6.17-6.14 (m, 1H), 5.94-5.85 (m, 1H), 5.44 (ddq, J = 6.6, 1.8 Hz, 1H), 5.11 (qd, J = 6.6, 
0.9 Hz, 1H), 4.91 (br s, 2H), 4.83-4.74 (m, 2H), 4.68 (d, J = 11.9 Hz, 1H), 3.68 (dt, J = 11.7, 
5.6 Hz, 1H), 3.15 (s, 3H), 2.68-2.56 (m, 1H), 2.47 (d, J = 6.9 Hz, 2H), 2.36-2.08 (m, 5H), 
2.05 (s, 3H), 1.88 (d, J = 1.3 Hz, 3H), 1.83 (d, J = 2.1 Hz, 3H), 1.74 (d, J = 2.3 Hz, 3H), 1.67 
(ddd, J = 14.8, 9.7, 5.1 Hz, 1H), 1.54-1.30 (m, 7H), 1.28 (d, J = 6.5 Hz, 3H), 1.06 (s, 3H), 
1.05 (s, 3H), 1.04 (s, 9H); 
13
C NMR (100 MHz, CDCl3): δ = 175.9, 170.1, 160.2, 153.9, 
150.8, 140.1, 139.4, 136.03 (2C), 136.00 (2C), 135.2, 134.2, 134.0, 129.8 (2C), 127.6 (4C), 
117.4, 113.4, 94.7, 83.0, 82.3, 77.9, 76.64, 76.57, 76.4, 74.8, 69.8, 65.7, 62.8, 56.6, 41.4, 41.2, 
41.1, 39.6, 38.0, 36.4, 34.2, 27.1 (3C), 24.4, 21.8, 21.2, 20.5, 19.5, 19.3, 18.2, 17.8, 3.8, 3.7; 
IR (film): ~  = 2962, 2932, 2858, 1753, 1737, 1448, 1428, 1377, 1249, 1162, 1110, 1064, 
1021, 970, 821, 733, 704, 611, 507, 489 cm
−1
; MS (ESI) m/z (%): 1050 (M+Na
+
, 100); HRMS 
(ESI): m/z: calcd. for C54H70Cl3NO10SiNa [M+Na
+








octadec-6-yn-8-yl acetate (32). In a flame-dried 1 L two-neck 
round-bottom flask, molecular sieve 4 Å (8 g) and 5 Å (19 g) 
were added to a solution of diyne 31 (1.62 g, 1.57 mmol) in 
toluene (830 mL). After stirring for 1 h, a solution of complex 
38 (640 mg, 0.483 mmol, 0.31 equiv)
14
 was dissolved in an 
aliquot (20 mL) of the reaction mixture and added. The resulting 
suspension was stirred for 45 min at ambient temperature before 
it was filtered through a plug of Celite which was rinsed with tert-butyl methyl ether 
(100 mL). The combined filtrates were evaporated and the residue was purified by flash 
chromatography (hexanes/ethyl acetate, 15:1 to 4:1) to give cycloalkyne 32 as a colorless 
syrup (1.21 g, 79%).  20D  = −1.5 (c = 1.02, CHCl3); 
1
H NMR (400 MHz, CDCl3): δ = 7.65-
7.59 (m, 4H), 7.46-7.30 (m, 7H), 6.18-6.12 (m, 1H), 6.08 (dd, J = 9.3, 1.8 Hz, 1H), 5.46 (ddd, 
J = 9.0, 4.3, 1.4 Hz, 1H), 5.15 (qd, J = 6.4, 0.8 Hz, 1H), 4.96 (br s, 1H), 4.94 (d, J = 1.1 Hz, 
1H), 4.84-4.66 (m, 3H), 3.91-3.77 (m, 1H), 3.19 (s, 3H), 2.63-2.18 (m, 7H), 2.06 (s, 3H), 1.95 
(ddd, J = 15.0, 7.1, 2.2 Hz, 1H), 1.89 (d, J = 1.3 Hz, 4H), 1.69-1.39 (m, 5H), 1.38-1.30 (m, 
2H), 1.27 (d, J = 6.5 Hz, 3H), 1.10 (d, J = 6.9 Hz, 3H), 1.07 (d, J = 6.9 Hz, 3H), 1.04 (s, 9H); 
13
C NMR (100 MHz, CDCl3): δ = 175.5, 169.9, 160.4, 153.9, 151.0, 140.9, 139.5, 135.9 (4C), 
135.1, 134.11, 134.06, 129.8 (2C), 127.7 (4C), 116.9, 113.3, 94.7, 90.6, 78.2, 78.1, 76.6, 74.8, 
70.2, 65.6, 63.4, 56.6, 41.9, 40.9, 40.7, 38.11, 38.09, 35.9, 34.1, 27.1 (3C), 24.1, 21.7, 21.3, 
20.5, 19.4, 19.3, 17.8, 17.1; IR (film): ~  = 2932, 2859, 1743, 1650, 1428, 1379, 1250, 1163, 
1111, 1021, 821, 739, 704, 613, 570, 508 cm
−1
; MS (ESI) m/z (%): 996 (M+Na
+
, 100); HRMS 
(ESI): m/z: calcd. for C50H64Cl3NO10SiNa [M+Na
+





oxooxacyclooctadec-6-yn-8-yl acetate (33). Zinc dust (1.55 g, 
23.6 mmol, Sigma-Aldrich
®
, < 10 μm) was added to a solution 
of compound 32 (230 mg, 0.236 mmol) in neat acetic acid (12 
mL). The suspension was sonicated for 15 min. (if TLC showed 
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unconsumed starting material, the same amount of zinc dust was added and sonication was 
continued until full conversion was reached). The suspension was filtered through a plug of 
Celite which was rinsed with ethyl acetate (20 mL). The combined filtrates were diluted with 
toluene (10 mL) and all volatile materials were evaporated. The residue was purified by flash 
chromatography (hexanes/ethyl acetate, 4:1 to 2:1) to give the title compound (175 mg, 93%) 
as a pale yellow oil.  20D  = −5.0 (c = 1.03, CHCl3); 
1
H NMR (400 MHz, CDCl3): δ = 7.64 
(dd, J = 7.9, 1.3 Hz, 2H), 7.62 (dd, J = 8.0, 1.3 Hz, 2H), 7.45-7.30 (m, 7H), 6.15 (dd, J = 1.5, 
0.8 Hz, 1H), 6.06 (dd, J = 9.2, 1.8 Hz, 1H), 5.44 (ddd, J = 8.3, 4.8, 1.4 Hz, 1H), 5.15 (qd, J = 
6.4, 0.8 Hz, 1H), 4.99 (br s, 1H), 4.97 (br s, 1H), 3.91-3.78 (m, 1H), 3.70-3.58 (m, 1H), 3.19 
(s, 3H), 2.60 (q, J = 6.9 Hz, 1H), 2.56-2.38 (m, 4H), 2.32 (ddd, J = 14.9, 9.4, 2.6 Hz, 1H), 
2.05 (s, 3H), 2.04-1.94 (m, 2H), 1.89 (d, J = 1.2 Hz, 3H), 1.72-1.52 (m, 4H), 1.51-1.42 (m, 
1H), 1.42-1.30 (m, 4H), 1.27 (d, J = 6.4 Hz, 3H), 1.09 (d, J = 7.0 Hz, 3H), 1.06 (d, J = 7.1 Hz, 
3H), 1.04 (s, 9H); 
13
C NMR (100 MHz, CDCl3): δ = 175.5, 169.8, 160.4, 150.9, 141.4, 140.9, 
135.9 (4C), 134.2, 134.14, 134.13, 129.78, 129.77, 127.7 (4C), 116.8, 113.4, 90.5, 78.3, 74.8, 
70.4, 68.8, 65.7, 63.7, 56.6, 45.0, 41.0, 40.6, 38.4, 38.0, 36.9, 35.9, 27.1, 24.0, 21.9, 21.3, 
20.4, 19.4, 19.3, 17.8, 17.0; IR (film): ~  = 3467, 2932, 2858, 1737, 1649, 1449, 1428, 1373, 
1232, 1162, 1105, 1022, 969, 900, 856, 822, 757, 704, 612, 509, 489 cm
−1
; MS (ESI) m/z (%): 
820 (M+Na
+
, 100); HRMS (ESI): m/z: calcd. for C47H63NO8SiNa [M+Na
+
]: 820.4215, found: 
820.4215. 
 
Compound 7-epi-33.  Prepared analogously; it analyzed as follows:  20D  = 25.0 (c = 1.00, 
CHCl3); 
1
H NMR (400 MHz, CDCl3): δ = 7.67-7.58 (m, 4H), 7.46-7.28 (m, 7H), 6.16-6.09 
(m, 2H), 5.51 (ddd, J = 7.1, 4.8, 2.0 Hz, 1H), 5.16 (q, J = 6.4 Hz, 1H), 4.98 (br s, 1H), 4.96 
(br s, 1H), 3.91-3.80 (m, 1H), 3.72-3.60 (m, 1H), 3.19 (s, 3H), 2.64-2.55 (m, 1H), 2.53-2.41 
(m, 4H), 2.32 (ddd, J = 14.8, 9.6, 2.1 Hz, 1H), 2.12-2.03 (m, 1H), 2.07 (s, 3H), 1.94 (ddd, J = 
15.0, 6.9, 2.1 Hz, 1H), 1.88 (d, J = 1.3 Hz, 3H), 1.84-1.71 (m, 1H), 1.66-1.56 (m, 2H), 1.55-
1.41 (m, 2H), 1.38-1.29 (m, 3H), 1.27 (d, J = 6.5 Hz, 3H), 1.25 (br s, 1H), 1.10 (d, J = 7.0 Hz, 
3H), 1.06 (d, J = 7.0 Hz, 3H), 1.04 (s, 9H); 
13
C NMR (100 MHz, CDCl3): δ = 175.4, 170.0, 
160.3, 150.8, 141.1, 141.0, 135.9 (4C), 134.2, 134.1 (2C), 129.8, 129.7, 127.6 (4C), 117.2, 
113.4, 90.5, 78.2, 74.8, 70.7, 68.8, 65.5, 63.1, 56.6, 45.1, 41.4, 40.5, 38.2, 38.1, 36.9, 36.2, 
27.1 (3C), 24.1, 22.4, 21.3, 20.4, 19.4, 19.3, 17.8, 17.2; IR (film): ~  = 3478, 2931, 2858, 
1739, 1648, 1451, 1428, 1373, 1233, 1164, 1109, 1026, 970, 902, 858, 822, 741, 704, 613, 
509, 488 cm
−1
; MS (ESI) m/z (%): 820 (M+Na
+
, 100); HRMS (ESI): m/z: calcd. for 
C47H63NO8SiNa [M+Na
+




Complex 39. A solution of chloro(dimethylsulfide)gold(I) (56.6 mg, 192 µmol) and (R) or 
(S)-3,5-tBu-4-MeO-Biphep (111 mg, 96.1 µmol) in CH2Cl2 (7 
mL) was stirred for 24 h at ambient temperature. The solvent 
was removed by a stream of argon and the colorless solid was 
dried on the high vacuum to obtain the title complex (quant.). 





H NMR (400 MHz, CDCl3): δ = 7.59 (td, J = 
8.1, 2.5 Hz, 2H), 7.39 (d, J = 13.7 Hz, 4H), 7.11 (br d, J = 
14.0 Hz, 4H), 7.02-6.86 (m, 4H), 3.72 (s, 6H), 3.69 (s, 6H), 
2.72 (s, 6H), 1.33 (s, 72H); 
31






yl acetate (34). Silver hexafluoroantimonate (2.94 mg, 
8.56 µmol, 0.34 equiv) and the gold complex (R)-39 (6.89 mg, 
4.26 µmol, 0.17 equiv) were suspended in CH2Cl2 (0.30 mL) 
and the mixture was sonicated for 5 min. The suspension was 
filtered through a plug of Celite (rinsing with CH2Cl2, 2 × 
0.25 mL) into a solution of compound 33 (20.0 mg, 25.1 
µmol) in CH2Cl2 (0.5 mL). After stirring for 48 h, the solvent 
was removed by a stream of argon and the residue was purified by flash chromatography 
(hexanes/ethyl acetate, 10:1) to give the title compound (18.1 mg, 91%) as a colorless oil. 
According to NMR, only the E-isomer has formed, which analyzed as follows:  20D  = −28.9 
(c = 0.98, CHCl3); 
1
H NMR (600 MHz, CDCl3): δ = 7.70 (m, 2H), 7.64 (m, 2H), 7.40 (m, 
1H), 7.37 (m, 1H), 7.34 (m, 2H), 7.32 (m, 2H), 7.15 (s, 1H), 6.08 (qd, J = 1.4, 1.0 Hz, 1H), 
5.93 (dd, J = 12.4, 3.4 Hz, 1H), 5.11 (qd, J = 6.5, 0.7 Hz, 1H), 5.04 (d, J = 3.5 Hz, 1H), 4.69 
(t, J = 1.8 Hz, 2H), 4.06 (ddd, J = 11.9, 3.5, 2.6 Hz, 1H), 3.74 (tdd, J = 10.2, 4.4, 1.8 Hz, 1H), 
3.39 (tt, J = 11.3, 1.8 Hz, 1H), 3.14 (s, 3H), 2.57 (dqd, J = 8.9, 7.0, 6.0 Hz, 1H), 2.53 (dqd, J = 
9.2, 6.9, 6.2 Hz, 1H), 2.33 (ddd, J = 13.9, 12.4, 4.4 Hz, 1H), 2.27 (ddd, J = 13.4, 2.5, 1.4 Hz, 
1H), 2.09 (s, 3H), 2.08 (ddtd, J = 13.4, 11.9, 1.6, 0.9, 1H), 2.08 (m,1H), 1.94 (ddtd, J = 13.3, 
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11.3, 1.6, 1.0 Hz, 1H), 1.87 (ddd, J = 13.9, 10.1, 3.5 Hz, 1H), 1.84 (d, J = 1.6 Hz, 3H), 1.83 
(m, 1H), 1.72 (t, J = 13.1 Hz, 1H), 1.67 (m, 1H), 1.33 (m, 2H), 1.25 (m, 1H), 1.23 (d, J = 6.5 
Hz, 3H), 1.16 (dd, J = 9.1, 6.1 Hz, 2H), 1.03 (s, 9H), 0.91 (d, J = 6.9 Hz, 3H), 0.69 (d, J = 6.8 
Hz, 3H); 
13
C NMR (150 MHz, CDCl3): δ = 175.0, 169.3, 160.1, 154.7, 151.0, 144.2, 141.0, 
136.1 (2C), 135.9 (2C), 134.9, 133.8, 133.4, 129.7, 129.5, 127.7 (2C), 127.4 (2C), 119.9, 
113.0, 109.1, 74.7, 74.6, 72.8, 71.7, 64.9, 56.5, 41.4, 40.95, 40.94, 40.0, 37.7, 34.5, 34.3, 32.8, 
27.1 (3C), 22.0, 21.0, 20.0, 19.4, 19.0, 18.1, 17.6; IR (film): ~  = 2934, 2858, 1759, 1733, 
1653, 1456, 1428, 1367, 1258, 1194, 1163, 1106, 1056, 1024, 899, 821, 743, 704, 610, 511, 
491, 451 cm
−1
; MS (ESI) m/z (%): 820 (M+Na
+
, 100); HRMS (ESI): m/z: calcd. for 
C47H63NO8SiNa [M+Na
+






acetate (40). The reaction was performed analogously, 
using (S)-39 as precatalyst. Flash chromatography 
(hexanes/ethyl acetate, 10:1) gave product 34 (50-70%) as 
an inseparable mixture of the E and Z isomers (~ 4:1) and 
product 40 (20-30%), which analyzed as follows: 
1
H NMR (600 MHz, CDCl3): δ = 7.59 (m, 
2H), 7.57 (m, 2H), 7.38 (m, 1H), 7.36 (m, 1H), 7.31 (m, 2H), 7.28 (m, 2H), 7.24 (s, 1H), 6.09 
(qd, J = 1.4, 1.0 Hz, 1H), 6.07 (dd, J = 9.2, 2.4 Hz, 1H), 5.13 (t, J = 2.5 Hz, 1H), 5.06 (qd, J = 
6.4, 0.8 Hz, 1H), 3.86 (dddd, J = 8.0, 6.9, 5.7, 2.3 Hz, 1H), 3.60 (m, 1H), 3.12 (s, 3H), 2.62 
(dd, J = 17.5, 2.7 Hz, 1H), 2.41 (dd, J = 17.5, 2.2 Hz, 1H), 2.39 (dqi, J = 7.0, 6.7 Hz,1H), 2.21 
(ddd, J = 15.1, 9.2, 2.4 Hz, 1H), 2.10 (s, 3H), 1.91 (ddd, J = 15.1, 8.0, 2.5 Hz, 1H), 1.85 (d, J 
= 1.4 Hz, 3H), 1.78 (m, 1H), 1.72 (m, 1H) 1.66 (dd, J = 14.4, 3.1 Hz, 1H), 1.54 (m, 1H), 1.52 
(ddd, J = 14.4, 10.2, 1.1, 1H), 1.45 (m, 2H), 1.42 (m, 1H), 1.39 (m, 1H), 1.35 (m, 1H), 1.25 
(d, J = 6.5 Hz, 3H), 1.21 (m, 1H), 1.05 (d, J = 7.0 Hz, 3H), 1.04 (m, 1H), 1.02 (s, 9H), 0.93 
(d, J = 7.1 Hz, 3H), 0.60 (dd, J = 4.0, 0.8 Hz, 1H), 0.41 (d, J = 4.0 Hz, 1H); 
13
C NMR (150 
MHz, CDCl3): δ = 176.0, 168.3, 160.1, 153.7, 150.6, 140.4, 135.8 (2C), 135.7 (2C), 134.3, 
134.2 (2C), 129.6 (2C), 127.49 (2C), 127.48 (2C), 113.2, 110.5, 74.7, 73.3, 70.7, 65.2, 56.4, 
40.9, 40.5, 39.8, 38.7, 37.6, 36.8, 36.6, 36.5, 31.0, 29.6, 27.0 (3C), 24.1, 21.3, 20.7, 20.4, 






1(1,3)-benzenacyclotetradecaphan-5-one (41). Prepared 
analogously starting with 7-epi-33, using (R)-39 as the 
precatalyst. The crude product was purified by preparative 
LC (Kromasil 100-5C18 5µm, 150 mm × 21.2 mm, 
MeCN/H2O, 95:5, 35 °C, 20 mL/min) to give 34 (10-20%) 
as an inseparable mixture of the E and Z isomers (~4:1) and 
compound 41 (~50%), which analyzed as follows: 
1
H NMR (600 MHz, CDCl3): δ = 7.61 (m, 
2H), 7.60 (m, 2H), 7.42 (s, 1H), 7.39 (m, 1H), 7.38 (m, 1H), 7.32 (m, 4H), 7.25 (t, J = 7.6 Hz, 
1H), 7.16 (t, J = 1.7, 1H), 7.08 (ddd, J = 7.5, 1.3, 1.3 Hz, 1H), 7.06 (ddd, , J = 7.4, 2.9 Hz, 
1H), 6.17 (dd, J = 10.8, 2.4 Hz, 1H), 6.14 (qd, J = 1.4, 0.9 Hz, 1H), 5.25 (qd, J = 6.4, 0.5 Hz, 
1H), 3.94 (dddd, J = 10.3, 6.5, 4.8, 1.2 Hz, 1H), 3.83 (br s, 1H), 3.19 (s, 3H), 2.89 (dd, J = 
13.9, 4.4 Hz, 1H), 2.81 (dd, J = 13.9, 2.8 Hz, 1H), 2.61 (dqd, J = 12.2, 7.0, 3.1 Hz, 1H), 2.56 
(ddd, J = 15.2, 10.8, 1.2 Hz, 1H), 2.10 (dqd, J = 11.4, 6.9, 2.5 Hz, 1H), 1.85 (d, J = 1.5 Hz, 
3H), 1.80 (ddd, J = 15.2, 6.5, 2.5 Hz, 1H), 1.74 (ddd, J = 13.8, 11.4, 3.1 Hz, 1H), 1.59 (m, 
1H), 1.51 (m, 1H), 1.44 (m, 1H), 1.42 (m, 1H), 1.34 (br s, 1H), 1.24 (m, 1H), 1.19 (d, J = 6.5 
Hz, 3H), 1.08 (d, J = 7.0 Hz, 3H), 1.03 (s, 9H), 1.01 (m, 2H), 1.00 (d, J = 6.9 Hz, 3H); 
13
C 
NMR (150 MHz, CDCl3): δ = 176.7, 160.2, 150.7, 146.4, 140.8, 135.78 (2C), 135.77 (2C), 
135.4, 134.4, 134.2, 134.1, 132.3, 129.7, 129.6, 128.7, 128.0, 127.6 (2C), 127.5 (2C), 122.9, 
113.2, 74.7, 71.1, 70.7, 65.3, 56.5, 45.6, 39.9, 37.4, 37.1, 36.8, 36.0, 35.6, 27.0 (3C), 22.5, 





Potassium carbonate (32.7 mg, 237 µmol) was added to a 
solution of compound 34 (63.0 mg, 78.9 µmol) in methanol (10 
mL). After stirring 3 h, the mixture was filtered through a plug 
of Celite which was rinsed with tert-butyl methyl ether (10 mL). 
The combined filtrates were concentrated and the residue was 
purified by flash chromatography (hexanes/ethyl acetate, 10:1) 
to give the title compound (56.8 mg, 95%) as a colorless oil. 
 20D  = −28.6 (c = 1.14, CHCl3); 
1
H NMR (400 MHz, CDCl3): δ = 7.70 (dd, J = 7.9, 1.4 Hz, 
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2H), 7.64 (dd, J = 7.9, 1.4 Hz, 2H), 7.46-7.30 (m, 6H), 7.21 (d, J = 0.8 Hz, 1H), 6.12 (qd, 
J = 1.4, 0.8 Hz, 1H), 5.95 (dd, J = 11.4, 2.8 Hz, 1H), 5.14 (qd, J = 6.4, 0.8 Hz, 1H), 4.75-4.68 
(m, 2H), 3.76- 3.62 (m, 1H), 3.54 (dd, J = 10.4 Hz, 1H), 3.39 (dd, J = 10.4 Hz, 1H), 3.16 (s, 
3H), 2.81 (dd, J = 15.4, 9.9 Hz, 1H), 2.70-2.61 (m, 1H), 2.41-2.25 (m, 2H), 2.25-2.06 (m, 
3H), 2.01-1.90 (m, 3H), 1.87 (d, J = 1.4 Hz, 3H), 1.80-1.71 (m, 3H), 1.41-1.30 (m, 5H), 1.26 
(d, J = 6.6 Hz, 3H), 1.05 (s, 9H), 0.99 (d, J = 6.8 Hz, 3H), 0.85 (d, J = 7.2 Hz, 3H); 
13
C NMR 
(100 MHz, CDCl3): δ = 212.9, 175.0, 160.3, 151.1, 144.0, 141.1, 136.2 (2C), 136.0 (2C), 
134.7, 133.8, 133.7, 129.9, 129.7, 127.8 (2C), 127.6 (2C), 113.2, 109.4, 75.2, 74.8, 74.3, 71.4, 
65.0, 56.6, 48.5, 42.9, 41.4, 40.8, 40.5, 39.0, 36.0, 35.0, 33.9, 27.2 (3C), 20.8, 19.6, 19.3, 
18.8, 17.8, 17.7; IR (film): ~  = 2932, 2857, 1729, 1703, 1652, 1456, 1428, 1380, 1259, 1163, 
1103, 1058, 892, 821, 804, 755, 702, 611, 509, 488 cm
−1
; MS (ESI) m/z (%): 778 (M+Na
+
, 
100); HRMS (ESI): m/z: calcd. for C45H61NO7SiNa [M+Na
+





Sodium borohydride (12.5 mg, 331 µmol) was added at 40 °C 
to a solution of ketone 35 (50.0 mg, 66.1 µmol) in MeOH (5 
mL). After stirring for 3 h at this temperature, excess reagent was 
quenched with aq. phosphate buffer (pH 7, 10 mL) and the 
solution was allowed to reach ambient temperature. The aqueous 
phase was extracted with tert-butyl methyl ether (3 x 10 mL) and 
the combined extracts were dried over MgSO4, filtered and 
concentrated. The crude product was purified by flash chromatography (hexanes/ethyl acetate, 
8:1 to 2:1) to yield 36 (30.8 mg, 61%) and 5-epi-36 (16.4 mg, 33%), each as a colorless oil.  
Analytical data of compound 36:  20D  = −31.4 (c = 1.50, CHCl3); 
1
H NMR (400 MHz, 
CDCl3): δ = 7.72 (dd, J = 7.9, 1.5 Hz, 2H), 7.67 (dd, J = 7.9, 1.5 Hz, 2H), 7.45-7.32 (m, 6H), 
7.28 (d, J = 0.6 Hz, 1H), 6.14-6.11 (m, 1H), 5.72 (dd, J = 11.9, 3.3 Hz, 1H), 5.12 (qd, J = 6.5, 
0.9 Hz, 1H), 4.70-4.64 (m, 2H), 3.85-3.66 (m, 2H), 3.35-3.19 (m, 2H), 3.17 (s, 3H), 2.52 
(dqd, J = 10.3, 7.0, 3.6 Hz, 1H), 2.41 (ddd, J = 14.0, 12.1, 3.9 Hz, 1H), 2.13 (br s, 1H), 2.09 
(br s, 1H), 2.01-1.88 (m, 4H), 1.87 (d, J = 1.4 Hz, 3H), 1.77-1.50 (m, 7H),1.48-1.30 (m, 4H), 
1.26 (d, J = 6.5 Hz, 3H), 1.05 (s, 9H), 0.94 (d, J = 7.0 Hz, 3H), 0.71 (d, J = 6.7 Hz, 3H); 
13
C 
NMR (100 MHz, CDCl3): δ = 175.8, 160.2, 151.1, 145.0, 140.8, 136.2 (2C), 136.0 (2C), 
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134.7, 134.3, 134.0, 129.8, 129.6, 127.8 (2C), 127.6 (2C), 113.3, 108.5, 77.2, 76.0, 75.2, 74.9, 
71.2, 68.7, 65.9, 56.6, 41.9, 41.7, 41.4, 41.0, 37.9, 36.3, 35.6, 33.8, 33.6, 27.3 (3C), 21.4, 
19.6, 19.2, 17.7, 16.5, 13.5; IR (film): ~  = 3468, 2933, 2857, 1726, 1652, 1549, 1454, 1428, 
1380, 1248, 1204, 1150, 1103, 1044, 1005, 976, 955, 891, 822, 756, 703, 611, 510, 488 cm
−1
; 
MS (ESI) m/z (%): 780 (M+Na
+
, 100); HRMS (ESI): m/z: calcd. for C45H63NO7SiNa 
[M+Na
+
]: 780.4266, found: 780.4266. 
Analytical data of compound 5-epi-36: 
1
H NMR (400 MHz, CDCl3): δ = 7.71 (dd, J = 7.9, 1.5 
Hz, 2H), 7.66 (dd, J = 7.9, 1.5 Hz, 2H), 7.46-7.33 (m, 6H), 7.25 (d, J = 0.6 Hz, 1H), 6.14-6.11 
(m, 1H), 5.84 (dd, J = 11.3, 3.2 Hz, 1H), 5.10 (qd, J = 6.4, 0.8 Hz, 1H), 4.69 (br s, 2H), 3.8-
3.75 (m, 1H), 3.57-3.24 (m, 4H), 3.17 (s, 3H), 2.92-2.81 (m, 1H), 2.32 (ddd, J = 14.5, 11.4, 
3.4 Hz, 1H), 2.13 (br d, J = 13.0 Hz, 1H), 2.10 (br d, J = 11.9 Hz, 1H), 2.04-1.88 (m, 3H), 
1.86 (d, J = 1.4 Hz, 3H), 1.79-1.29 (m, 11H), 1.25 (d, J = 6.4 Hz, 3H), 1.03 (s, 9H), 0.92 (d, J 
= 6.8 Hz, 3H), 0.77 (d, J = 6.4 Hz, 3H); 
13
C NMR (100 MHz, CDCl3): δ = 176.9, 160.3, 
151.1, 144.9, 141.0, 136.1 (2C), 136.0 (2C), 134.7, 134.0 (2C), 129.8, 129.6, 127.8 (2C), 
127.6 (2C), 113.3, 108.6, 76.0, 75.5, 75.2, 74.9, 71.3, 65.8, 56.6, 41.9, 41.5, 40.9, 40.4, 40.2, 
39.2, 35.7, 35.0, 33.9, 27.2 (2C), 21.4, 19.6, 19.2, 18.0, 17.8, 17.2. 
Bis-((9H-fluoren-9-yl)methyl) ((1R,3S,4S,6S,9S,11S,15R)-11-((tert-butyldiphenylsilyl)-
oxy)-9-(2-((R,Z)-3-methoxy-2-methylbut-1-en-1-yl)oxazol -4-yl)-4,6-dimethyl-17-
methylene-7-oxo-8,19-dioxa bicyclo[13.3.1]nonadecan-3-yl) phosphate (37). A solution of 
a tetrazole (0.45 M in MeCN, 264 µL, 119 µmol) was 
added at 0 °C to a solution of alcohol 36 (30.0 mg, 39.6 
µmol) and iPr2NP(OFm)2 (62.9 mg, 119 µmol)
22
 in 
MeCN (0.75 mL) and CH2Cl2 (0.75 mL). The mixture 
was stirred for 3 h at ambient temperature before it was 
cooled to 0 °C and aq. hydrogen peroxide (35% w/w, 115 
µL, 1.19 mmol) was added. After stirring for additional 
30 min, the reaction was quenched with aq. sat. NaHCO3 
(5 mL). The aqueous phase was extracted with CH2Cl2 (3 
× 5 mL) and the combined extracts were washed with brine, dried over MgSO4, filtered and 
concentrated. The residue was purified by flash chromatography (hexanes/ethyl acetate, 6:1 to 
2:1) to afford the title compound (47.1 mg, quant.) as a colorless solid.  20D  = −11.1 (c = 
2.35, CHCl3); 
1
H NMR (600 MHz, CDCl3): δ = 7.74 (d, J = 7.6 Hz, 1H), 7.71 (d, J = 7.6 Hz, 
1H), 7.71 (d, J = 7.6 Hz, 1H), 7.69 (m, 3H), 7.63 (m, 2H), 7.52 (d, J = 7.5 Hz, 2H), 7.50 (d, J 
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= 7.5 Hz, 1H), 7.44 (d, J = 7.5 Hz, 1H),7.39-7.33 (m, 10H), 7.27 (td, J = 7.5, 1.0 Hz, 1H), 
7.26 (td, J = 7.4, 1.1 Hz, 1H), 7.25 (td, J = 7.4, 1.1 Hz, 1H), 7.21 (td, J = 7.5, 1.1 Hz, 1H), 
7.15 (s, 1H), 6.08 (s, 1H), 5.79 (dd, J = 12.5, 2.9 Hz, 1H), 5.11 (q, J = 6.5 Hz, 1H), 4.68 (m, 
2H), 4.51 (dddd, J = 11.6, 6.8, 4.8, 1.0 Hz, 1H), 4.23-4.14 (m, 4H), 4.10 (m, 2H), 3.59 (m, 
1H), 3.23 (tt, J = 11.1, 2.0 Hz, 1H), 3.14 (s, 3H), 2.98 (ddd, J = 11.4, 9.1, 2.3 Hz, 1H), 2.55 
(dqd, J = 12.7, 6.7, 4.0 Hz, 1H), 2.26 (ddd, J = 13.7, 12.5, 4.0 Hz, 1H), 2.07 (d, J = 13.3 Hz, 
1H), 1.97 (d, J = 13.1 Hz, 1H), 1.84 (m, 1H), 1.84 (d, J = 1.5 Hz, 3H), 1.84 (m, 1H), 1.83 (m, 
1H), 1.82 (m, 1H), 1.80 (m, 1H), 1.64 (dd, J = 14.0, 4.7 Hz, 1H), 1.63 (ddd, J = 12.4, 9.6, 1.6 
Hz, 1H), 1.58 (m, 1H), 1.40 (m, 1H), 1.30 (m, 2H), 1.23 (d, J = 6.5 Hz, 3H), 1.21 (m, 1H), 
1.20 (m, 1H), 1.02 (s, 9H), 0.83 (td, J = 13.3, 3.0 Hz, 1H), 0.78 (d, J = 6.7 Hz, 3H), 0.60 (d, J 
= 6.5 Hz, 3H); 
13
C NMR (150 MHz, CDCl3): δ = 174.0, 160.1, 151.0, 144.5, 143.15, 143.13, 
143.12, 143.05, 141.34 (3C), 141.31, 141.2, 136.1 (2C), 135.9 (2C), 134.8, 133.6, 133.3, 
129.7, 129.5, 127.90, 127.87 (2C), 127.84, 127.7 (2C), 127.4 (2C), 127.14, 127.12, 127.11, 
127.07, 125.2, 125.03, 125.00 (2C), 120.09, 120.03, 120.02, 120.00, 113.0, 108.6, 78.5 (d, JC-
P = 7.0 Hz), 74.72, 74.69, 74.3, 71.3, 69.2 (d, JC-P = 5.9 Hz), 68.9 (d, JC-P = 6.1 Hz), 64.9, 
56.5, 48.0 (d, JC-P = 5.4 Hz), 47.9 (d, JC-P = 5.8 Hz), 41.7, 41.5, 41.2, 38.6, 37.9, 37.5, 35.1, 
33.3, 33.2 (d, JC-P = 6.6 Hz), 27.1 (3C), 21.1, 19.5, 19.0, 17.6, 17.4, 13.7; 
31
P NMR 
(160 MHz, CDCl3): δ = 0.00 (s); IR (film): 
~  = 3069, 2934, 2892, 2857, 1727, 1450, 1428, 
1381, 1261, 1205, 1150, 1105, 1045, 1003, 988, 914, 823, 757, 740, 704, 612, 511, 494 cm
−1
; 
MS (ESI) m/z (%): 1217 (M+Na
+
, 100); HRMS (ESI): m/z: calcd. for C73H84NO10PSiNa 
[M+Na
+
]: 1216.5494, found: 1216.5494. 
 
Enigmazole A (1). A solution of tetrabutylammonium fluoride (1 M in THF, 188 µL, 188 
µmol) was added to a solution of compound 37 (4.50 mg, 
3.77 µmol) in THF (0.5 mL) and acetic acid (16.2 µL, 283 
µmol,) and the resulting mixture was stirred at 40 °C for 9 
d. After reaching ambient temperature, the solution was 
diluted with water (1 mL) and loaded onto a C18-cartridge 
(Strata
®
 C18-U, 55 µm, 70 Å, 500 mg/6 mL). The salts 
were eluted with water, followed by elution of the organic 
fraction with MeOH. The combined organic fractions was 
concentrated and the residue purified by preparative LC 
(Kromasil 100-5C18 5µm, 150 mm × 21.2 mm, MeOH/aq. 
TEAA pH 8.0, 70:30 to 100% MeOH over 10 min, 35 °C, 20 mL/min) to obtain the 
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tetrabutylammonium salt of enigmazole A (2.60 mg, 82%) as a colorless powder after 
lyophilisation.  
Purification by preparative LC (amount < 0.5 mg, Kromasil 100-5C18 5µm, 150 mm × 21.2 
mm, MeCN/aq. TEAA pH 8.0, 30:70 to 50:50 over 6 min, 35 °C, 20 mL/min) afforded the 
triethylammonium salt of Enigmazole A (quant.) after lyophilisation. 
The protonated form of Enigmazole A was obtained by ion exchange chromatography 
(Adsorbex
®
 SCX 400 mg) using MeOH as eluent. 




C NMR data, see Tables S1 
and S2;  20D  = −9.7 (c = 0.50, CHCl3); 
31
P NMR (160 MHz, CDCl3): δ = 0.00 (s); IR (film): 
~  = 3402 (br), 2977, 2935, 2854, 1726, 1651, 1455, 1252, 1203, 1150, 1109, 1076, 1017, 
972, 936, 896, 657, 594, 515, 497 cm
−1
; MS (ESI) m/z (%): 598 (M−H−, 100); HRMS (ESI): 
m/z: calcd. for C29H45NO10P [M−H
−
]: 598.2787, found: 598.2787;  




C NMR data, see Tables S1 and S2; 
31
P 





Table S1: Comparison of 
1
H NMR data (CD3OD) of Enigmazole A;  














9 7.68, s 7.69, s 7.68, d, 0.5 7.68, d, 0.4 
21 6.21, s 6.22, br s 6.21, qd, 1.4, 1.0 6.20, qd, 1.4, 1.0  
17 5.95, dd, 12.8, 2.5 5.96, dd, 12.5, 2.5 5.95, ddd, 12.8, 2.8, 0.5 5.95, ddd, 12.8, 2.9, 0.4  
23 5.24, q, 6.5 5.25, q, 6.3 5.24, qd, 6.5, 0.9 5.23, qd, 6.5, 0.9 
28a 4.70, d, 1.5 4.71, br s 4.70, q, 2.0 4.70, q, 1.9 
28b 4.69, d, 1.5 4.70, br s 4.69, q, 2.0 4.69, q, 1.9 
5 4.42, m 4.43, m 4.42, dddd, 11.2, 8.8, 4.4, 1.0 4.47, m 
15 3.62, dt, 11.1, 4.3 3.63, m 3.60, tdd, 10.8, 4.1, 1.8 3.60, tdd, 10.8, 4.1, 1.8  
11 3.29 3.30 3.30, tt, 11.0, 2.4 3.29, tt, 11.1, 2.4  
23-OMe 3.20, s 3.21, s 3.20, s 3.19, s 
Et3NH - - 3.17, q, 7.3  - 
7 3.12, dd, 10.3, 9.8 3.13, m 3.12, ddd, 11.4, 8.6, 2.3  3.12, ddd, 11.4, 8.6, 2.0  
2 2.98 2.99, m 2.98, dqd, 12.5, 6.7, 3.8 2.95, m  
16a 2.50, dt, 13.2, 3.4 2.51, dt, 13.3, 3.8 2.50, ddd, 13.8, 12.8, 4.1 2.50, ddd, 13.8, 12.8, 4.1  
8a 2.21, d, 12.8 2.23, d, 13.0 2.21, ddd, 13.0, 2.3, 1.2 2.20, br d, 13.2  
10a 2.13, d, 12.8 2.14, d, 14.0 2.13, ddd, 13.1, 2.4, 1.2 2.13, br d, 13.2  
6a 2.10, m 2.11, m 2.09, dd, 14.4, 4.4 2.07, br d, 14.4  
8b 1.97, dd, 12.8, 12.3 1.98, t, 12.3 1.97, ddtd, 13.0, 11.4, 1.7, 1.0 1.97, m 
25 1.89, s 1.89, d, 1.5 1.88, d, 1.6 1.88, d, 1.5 
3a 1.88, m 1.89, m 1.88, m 1.87, m 
6b 1.87, m 1.88, m 1.87, m 1.90, m 
10b 1.84 1.86 1.85, m 1.84, m 
14a 1.76 1.79 1.78, m 1.78, tt, 12.9, 1.9  
16b 1.77 1.78 1.77, ddd, 13.8, 10.8, 2.9 1.77, ddd, 13.8, 10.8, 2.9 
13a 1.72 1.73 1.72, m 1.72, tq, 13.0, 3.8 
12a 1.64 1.66 1.65, m 1.64, dddd, 14.0, 11.2, 3.8, 2.8 
4 1.62 1.63 1.64, m 1.64, m 
13b 1.54, q, 12.4 1.55, q, 12.5 1.53, tdt, 13.0, 12.6, 2.9 1.52, tdt, 13.0, 12.7, 2.8 
3b 1.38, t, 10.8 1.39, m 1.40, m 1.41, td, 13.2, 2.5 
12b 1.37, t, 11.3 1.38, m 1.38, m 1.37, dddd, 14.0, 13.2, 3.3, 2.4 
Et3NH - - 1.30, t, 7.3  - 
24 1.26, d, 6.4 1.27, d, 6.5 1.26, d, 6.5  1.26, d, 6.5 
26 1.10, d, 6.4 1.11, d, 6.5 1.10, d, 6.7  1.10, d, 6.6 
14b 1.02, td, 12.0, 3.4 1.04, dt, 12.0, 3.2 1.02, m 1.02, tdd, 12.8, 11.2, 4.1 





Table S2: Comparison of 
13
C NMR data (CD3OD) of Enigmazole A;  















1 176.4 176.5 176.5 176.5 
20 161.7 161.9 161.9 161.9 
22 152.7 152.7 152.7 152.7 
9 146.3 146.6 146.6 146.5 
18 142.3 142.4 142.4 142.3 
19 136.0 135.9 135.9 135.9 
21 113.9 114.0 114.0 114.0 
28 108.8 108.6 108.7 108.7 
7 77.2 77.6 77.5 77.4 
23 77.0 76.2 76.2 76.2 
11 76.2 75.7 75.8 75.9 
5 75.8 75.2, d, 6.1 75.4,d ,6.3 75.8, br 
15 69.8 69.8 69.8 69.8 
17 65.9 65.6 65.7 65.8 
23-OMe 56.8 56.8 56.8 56.8 
Et3NH - - 47.6 - 
8 43.0 43.0 43.1 43.1 
16 42.6 42.7 42.7 42.6 
10 42.4 42.5 42.5 42.5 
6 40.1 40.1 40.2 40.1 
2 39.6 39.7 39.7 39.7 
3 39.3 39.3 39.4 39.3 
4 36.2 34.7, d, 6.1 34.7, d, 6.4 34.7 d, 4.6 
12 36.2 36.2 36.2 36.2 
14 33.6 33.6 33.6 33.6 
13 21.8 21.8 21.8 21.8 
24 19.4 19.4 19.4 19.4 
26 18.2 18.3 18.3 18.3 
25 17.6 17.7 17.7 17.7 
27 14.7 15.0 15.0 14.9 
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Comparison of Molinski’s 
13
C NMR (top) and Fürstner’s (bottom)  
